The Functions and Importance of CH···O Bonds in SET Domain Methyltransferases. by Horowitz, Scott A.
 
The Functions and Importance of CH···O Bonds in SET Domain 
Methyltransferases 
by 
Scott A. Horowitz 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy  
(Biophysics) 






Professor Hashim M. Al-Hashimi, Co-Chair 
Associate Professor Raymond C. Trievel, Co-Chair 
Professor Charles L. Brooks III 
Assistant Professor Tomek Cierpicki 
Professor Anna K. Mapp 
 




I would like to first and foremost thank Profs. Ray Trievel and Hashim Al-
Hashimi. I consider myself lucky to have been able to learn two different approaches to 
a scientific problem from two tremendous scientists. I would also like to thank my 
dissertation committee for their many useful suggestions over the years. 
I would like to thank everyone from the Trievel and Al-Hashimi groups, many of 
whom have aided and taught me over the years. In particular, Paul Del Rizzo taught me 
much of what I know about working with proteins and biochemistry, and Jennifer 
Nimtz was extremely helpful in protein crystallization. Alex Hansen has given me 
enormous support learning advanced NMR concepts, and most importantly, Joseph 
Yesselman has been an enthusiastic collaborator on many facets of this work, without 
whom I would not have been able to complete much of what is presented here. 
Also, many collaborators from outside the university have been instrumental in 
this work. Most notably, Lynnette Dirk and Bob Houtz performed the radiometric 
assays, and gladly took up each new challenge as it came. Also, the advice of Ryan 
Mehl provided essential advice on making protein with unnatural amino acids and the 
help of Sam Butcher and Kirk van der Meulen helped us considerably with ITC 
analysis. And last but not least, Doug Markham was responsible for helping all of this 
get started in the first place with his gift of the AdoMet synthetase enzyme. 
iii 
Table of Contents 
Acknowledgements ..................................................................................................................... ii 
List of Tables ................................................................................................................................ iv 
List of Figures ............................................................................................................................... v 
List of Appendices .................................................................................................................... viii 
Abstract......................................................................................................................................... ix 
 : Introduction .............................................................................................................. 1 Chapter 1
 : Direct Evidence for Methyl Group Coordination by CH···O Hydrogen Bonds Chapter 2
in SET Domain Methyltransferases ......................................................................................... 27 
 : CH···O Hydrogen Bonds Mediate AdoMet-Dependent Methylation............ 43 Chapter 3
 : Conclusions and Future Directions ..................................................................... 79 Chapter 4
Appendix A ................................................................................................................................. 87 




List of Tables 
Table 2.1 Dissociation constants and binding enthalpies of AdoMet, Sinefungin, and 
AdoHcy to SET7/9 ...................................................................................................................... 40 
Table 3.1: Crystallographic statistics for structures of SET7/9 
Y335pAF•TAF10•AdoHcy, SET7/9 Y335F•TAF10•AdoHcy, SET7/9•TAF10 
K189A•AdoHcy, and SET7/9•TAF10 K189A•AdoMet. ...................................................... 63 
Table 3.2: WT SET7/9 and mutants Y335pAF, Y335F dissociation constants and catalytic 
parameters. .................................................................................................................................. 68 
Table 3.3: All AdoMet-C8···Tyr335-OH distances in high-resolution (<2.0 Å) SET7/9 




List of Figures 
Figure 1.1 AdoMet chemical structure ...................................................................................... 2 
Figure 1.2: SN2 mechanism of AdoMet-dependent methyl transfer.................................... 3 
Figure 1.3: Example of “loose” and “tight” transition states. ................................................ 4 
Figure 1.4: SET domain architecture. ........................................................................................ 8 
Figure 1.5: Oxygen-lined pore of SET domain methyltransferase. ....................................... 9 
Figure 1.6: Distance and angular parameters used when defining CH···O hydrogen 
bonds. ........................................................................................................................................... 11 
Figure 1.7: Timeline of important events in the history of CH···O hydrogen bonding 
research. ....................................................................................................................................... 13 
Figure 1.8 Examples of CH···O hydrogen bonds (orange dashes) in proteins. ................. 15 
Figure 1.9: Examples of CH···O hydrogen bonds (orange dashes) in nucleic acids. ........ 17 
Figure 1.10: Examples of CH···O hydrogen bonds (orange dashes) in molecular 
recognition and enzyme catalysis. ........................................................................................... 18 
Figure 1.11: Crystal structure of SET7/9 bound to AdoMet (47, 49). .................................. 26 
Figure 2.1: 2D-HSQC of SET7/913C-methyl AdoMet complex ........................................... 34 
Figure 2.2: Free AdoMet in implicit solvent. .......................................................................... 35 
Figure 2.3: Optimized and broken CH···O hydrogen bonds in SET7/9.............................. 36 
Figure 2.4: Chemical shift of the AdoMet methyl group as a function of rotation angle.37 
vi 
Figure 2.5: Binding modes of AdoMet (A), Sinefungin (B), and AdoHcy (C) to SET7/9 
are nearly identical. .................................................................................................................... 39 
Figure 2.6: ITC analysis of AdoMet binding to SET7/9. ....................................................... 40 
Figure 3.1: Selective 13C R1ρ relaxation and relaxation-dispersion pulse sequence for 
13CHD2-methyl groups. ............................................................................................................. 53 
Figure 3.2: 13C R1 relaxation pulse sequence for 13CHD2-methyl groups. .......................... 53 
Figure 3.3: Methyl CH···O hydrogen bonding in AdoMet-dependent methyltransferases.
....................................................................................................................................................... 57 
Figure 3.4: Angular distribution of methyl CH···O hydrogen bonds. ................................ 59 
Figure 3.5: Distance and angular distribution of methylene CH···O hydrogen bonds. ... 59 
Figure 3.6: Calorimetric analysis of SET7/9 Y335pAF. ............................................................. 61 
Figure 3.7: Structure of the SET7/9 Y335 mutants bound to AdoHcy and the TAF10 
peptide. ........................................................................................................................................ 62 
Figure 3.8 Ligand binding modes of WT and SET7/9 Y335pAF are conserved. ............... 63 
Figure 3.9: Model of SET7/9 Y335pAF hydrogen positions based on its crystal structure 
and density functional theory calculations. ........................................................................... 65 
Figure 3.10: WT SET7/9•AdoMet and SET7/9 Y335F•AdoMet methyl 1H chemical shift 
measurement. ............................................................................................................................. 66 
Figure 3.11: Representative injection peak and best-fit kinetic parameter trace from 
AdoMet•WT SET7/9 ITC experiments. .................................................................................. 66 
Figure 3.12: Measurement of cofactor binding affinity by intrinsic tryptophan 
fluorescence................................................................................................................................. 68 
Figure 3.13: Radiometric methyltransferase assays with varying AdoMet concentration.
....................................................................................................................................................... 69 
Figure 3.14: Triplicate single turnover experiments on SET7/9 at 37° C. ........................... 69 
Figure 3.15: Quantum chemistry geometry optimizations and interaction energies of 
AdoMet and methyl transfer transition state CH···O hydrogen bonds. ............................ 73 
vii 
Figure 3.16: Methyl transfer pore contraction in SET7/9. ........................................................... 75 
Figure 3.17: (A) R2 and (B) R1 13C spin relaxation fits of 13CHD2-methyl AdoMet bound 
to SET7/9. ..................................................................................................................................... 77 
Figure 3.18: Model of AdoMet-dependent methylation. ............................................................. 77 
Figure A.1: QM optimization of AdoMet methyl group bound to TylM1 ........................ 88 
Figure A.2: NMR spectrum of AdoMet bound to TylM1..................................................... 88 
Figure A.3: Preliminary diffraction analysis of crystals of deuterated SET7/9 bound to 
AdoHcy and a CD3-monomethyl-TAF10K189 peptide. ...................................................... 94 
Figure A.4: Methyl (C)H···O contact distances in proteins. ................................................. 96 
Figure A.5: Methyl C-H···O (orange) and C-H···C (black) angles. ...................................... 97 
Figure A.6 Methyl CH···O elevation angles ........................................................................... 97 
 
viii 
List of Appendices 
A.1 Direct Evidence of CH···O Hydrogen Bonding to AdoMet in Methyltransferase 
TylM1 ........................................................................................................................................... 87 
A.2 All AdoMet CH···O Hydrogen Bonds .......................................................................... 89 
A.3 Perdeuterated Diffraction of SET7/9 Crystals ............................................................. 93 




Methylation is a ubiquitous reaction in biology, particularly with respect to 
metabolism, signal transduction, and gene regulation. This reaction is most often 
catalyzed through a convergently evolved SN2 mechanism that utilizes the cofactor S-
adenosylmethionine (AdoMet). Despite its importance, little is known of the 
determinants of this conserved reaction. The following dissertation describes the 
discovery of one such determinant, unconventional CH···O hydrogen bonds. A new 
methodology utilizing NMR spectroscopy is first developed to identify biological 
CH···O hydrogen bonds, and applied to the AdoMet methyl group within the active site 
of model methyltransferase SET7/9. Using a structural survey, the universality of these 
interactions in the classes of AdoMet-dependent methyltransferases is then 
demonstrated. The functional importance of CH···O hydrogen bonds hydrogen within 
the active site of a model methyltransferase are verified by structural, functional, and 
dynamic analyses of SET7/9, using a combination of x-ray crystallography, mutagenesis 
with natural and unnatural amino acids, quantum chemistry calculations, and NMR 
spin-relaxation experiments. The CH···O hydrogen bonds are shown to aid in cofactor 
binding as well as catalysis by stabilizing both the reactant and transition states of 
methyl transfer, and optimizing the catalytic geometry of the AdoMet methyl group. 
Together, these studies elucidate a universal mechanism of AdoMet-dependent methyl 
transfer, providing a molecular framework for this integral biological reaction. 
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: Introduction Chapter 1
1.1 Mechanism and Structure of AdoMet Dependent Methyltransferases 
1.1.1 Mechanism of Methylation 
S-Adenosylmethionine (AdoMet) is the second most utilized substrate in the cell, 
after ATP (1). AdoMet comprises adenine and methionine molecules that are covalently 
linked through their C5’ and sulfur atoms, respectively, creating a sulfonium cation 
(Figure 1.1). The most common AdoMet-dependent reaction in eukaryotes is 
methylation, in which the single electrophilic AdoMet methyl group is transferred to a 
nucleophilic acceptor atom (N, O, S, or C). Cellular methyl acceptors are numerous, 
including proteins, RNA, DNA, natural products, amino acids, lipids, and hormones (2) 
In addition to metabolic functions, AdoMet-dependent methyltransferases also 
participate in signal transduction through, RNA (3), DNA, and protein methylation (4), 
as numerous proteins have evolved the function of “reading” the methylation status of 
specific residues. Dysfunction or misregulation of AdoMet-dependent methylation has 
been implicated in many diseases, including multiple forms of cancer (5-8), Parkinson’s 
Disease (9, 10), Alzheimer’s Disease (11, 12), HIV (13), and antibiotic-resistant bacterial 
infections (14-16). Due to its importance to many cellular functions as well as disease, 
determining the mechanism and specificity of AdoMet-dependent methylation has been 




Figure 1.1 AdoMet chemical structure 
In the 1970s, several groups attempted to determine the mechanism of AdoMet-
dependent methyl transfer. Many of the early studies used sulfonium-containing small 
molecules to model the methyl transfer reaction by mimicking the reactivity of the 
AdoMet sulfonium group. By analyzing the kinetic and thermodynamic properties of 
sulfonium containing molecules and reaction properties as a function of solvent and 
temperature, and comparing these parameters to known reactive compounds, these 
studies discovered that the reaction proceeds through an SN2 mechanism in which the 
methyl group is transferred directly to the acceptor atom, passing through a planar sp2 
transition state (17, 18) (Figure 1.2). Schowen and coworkers expanded upon these 
investigations in the enzyme catechol-o-methyltransferase (COMT), utilizing direct 
kinetic isotope effect (KIE) measurements to confirm the proposed SN2 mechanism. In 
these experiments, the authors used AdoMet containing either a 12C or 13C methyl 
group, and examined the maximal enzymatic rate in each case. The authors measured 
large kinetic isotope effect on the transferred group, indicating that methyl transfer was 
the rate limiting step of the reaction in COMT (19, 20). As a result of these studies, rate-





Figure 1.2: SN2 mechanism of AdoMet-dependent methyl transfer. 
Methyl acceptors can be O, S, C or N atoms. 
In addition to determining the rate-limiting step and general chemical 
mechanism of methylation, the aforementioned studies examined how 
methyltransferases could achieve their catalytic power. Although many catalyzed 
methyl transfer reactions are slow by enzymatic standards (usually slower than 1 s-1), 
this still accounts for a 1016 rate enhancement over the uncatalyzed reaction in solution 
(22). The sulfonium model studies discussed above were the first to suggest a mode for 
the acceleration, as they observed that the transfer reaction was faster when performed 
in a nonpolar environment, suggesting that a nonpolar active site aided in catalysis (17). 
The KIE studies refined this model by proposing additional details. Schowen and 
coworkers observed an unusually large inverse deuterium KIE for COMT (20), in which 
2D-methyl AdoMet caused a 20% increase in reaction rate compared to 1H-methyl 
AdoMet, suggesting that methyltransferases utilize a “tight” transition state (Figure 
1.3), in which the enzyme compresses, or shortens, the distance between the AdoMet 
sulfonium donor group and the oxygen acceptor, thereby creating a chemically distinct 
transition state that is preferentially bound by the enzyme (22, 23). After being verified 
by early computational models (23, 24) compression of the donor-acceptor distance in a 
nonpolar active site became the standard model for the AdoMet methyl transfer 




Figure 1.3: Example of “loose” and “tight” transition states. 
Methyltransferases were proposed to compress the donor-acceptor distances to create the “tight” 
transition state, shown right. 
By 1993, the computational methods used to support compression hypothesis 
were under fire (25). As computational quantum chemistry methods improved, a new 
wave of studies revisited the original KIE experiments by Schowen to try and determine 
the SN2 transition state structure in greater detail. These studies especially focused on 
factors that could have led to the inverse KIE, and to test the compression model. 
Updated QM/MM models often reversed previous thinking, concluding that the inverse 
KIE could be achieved without any active site compression (26, 27). Still, the 
compression hypothesis has not been entirely ruled out. A recent experimental study of 
COMT confirmed Schowen’s KIE measurements, and implied that active site 
compaction is involved in the methyltransferase mechanism. The authors questioned 
the validity of the QM/MM simulations on the basis of lingering computational 
limitations (28). 
As the debate over the compression hypothesis continues, other theories have 
risen to challenge it. One alternative proposal to compression posits that the primary 
purpose of a methyltransferase is to orient the reactants in an ideal methyl transfer 
position, termed the near-attack conformation (NAC), and that this pre-orientation is 
responsible for rate enhancement (29, 30). This hypothesis is also not without critics. 
Warshel and coworkers have contended that the near attack conformation in SN2 
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reactions is merely a byproduct of the enzyme’s attempts to stabilize the transition state 
by providing an electrostatically favorable environment that is more selective for the 
transition state than the surrounding solution (31). This contention has been supported 
by computations suggesting that the primary purpose of the enzyme is to selectively 
recognize and stabilize the transition state over the reactant states through hydrogen 
bonding and favorable active site electrostatics (26). Complicating matters, 
computational studies by Williams and coworkers have shown that sampling of 
different dynamic reactant states in the enzyme can lead to multiple different possible 
attack conformations that averaged together can yield the experimentally-determined 
KIEs, questioning the notion that the experimental transition state can be accurately 
described by any single structure (32). Although these studies have questioned the 
long-held notion of active site compression and provide interesting and plausible 
alternatives, difficulties in experimentally observing the properties and structure of the 
transition state have prevented them from being experimentally tested to date. As a 
result, the methyl transfer community is still attempting to answer a major question that 
was first addressed over thirty years ago: how does the methyltransferase enhance the 
methyl transfer rate? 
1.1.2 Structure of AdoMet-Dependent Methyltransferases 
At the outset of methyltransferase structural investigation, the primary theory 
was that methyltransferases were not structurally similar given their low sequence 
conservation. Thus, it was a surprise when the first crystal structures of 
methyltransferases, Hhal in 1993 (33) and COMT (34) in 1994, revealed that these 
enzymes fold into highly similar structures despite low sequence homology. They each 
contain a Rossmann-like fold, consisting of a seven strand β-sheet buttressed by six 
flanking alpha helices. As more methyltransferase crystal structures were solved, this 
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fold was repeatedly observed, leading it to be named the “consensus methyltransferase 
fold” (35). Despite maintaining the same fold, AdoMet conformation, and AdoMet 
binding position, the sequence conservation in the active site of these enzymes 
remained surprisingly low, even in the AdoMet binding pocket. It was hypothesized 
that this low sequence homology was required to allow methylation of a variety of 
substrates while maintaining the same structure (35). This was unexpected, because 
often function is preserved through conserved sequence. Further, the low sequence 
conservation obscured mechanistic insights of methyltransferases, as it became difficult 
to attribute functions to specific functional groups in the enzyme active site. 
Despite the title of “consensus methyltransferase fold”, this conclusion was 
based on a limited number of structures, and it was not long before other AdoMet-
dependent methyltransferase architectures were discovered. By 1996, a second class of 
methyltransferase had been found that was structurally distinct from the Rossmann-like 
Class I enzymes (36). In the intervening years, many more structural classes have been 
discovered and come to the fore. As of today, there are as many as nine unrelated 
structural classes of AdoMet-dependent methyltransferases (37). This expanding set of 
structural classes was first categorized by Cheng et al. in 2003, shortly after the 
discovery of the fifth class, the SET domain superfamily. Cheng proposed the well-
accepted theory that AdoMet-dependent methylation evolved convergently, with 
different structural classes emerging to methylate novel substrates as organisms 
developed the need (38). Despite having no homology in sequence, structure, AdoMet 
binding mode, or substrate specificity, it is generally thought that these enzymes all 
catalyze methylation using the same SN2 mechanism, (in the case of the radical SAM 
methyltransferases, as the first part of a multi-step mechanism (39)) with generally the 
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same properties (40, 41). Despite this similarity in catalytic mechanism, no common 
structural properties of all methyltransferase classes have yet been defined. 
After Class I, the most studied methyltransferase class is Class V, or the SET 
domain class. This class is primarily responsible for lysine methylation on both histone 
and non-histone substrates in eukaryotes, with over fifty separate family members in 
humans that regulate functions such as gene transcription, cell cycle progression, and 
epigenetic inheritance (42, 43). These enzymes all contain a highly conserved SET 
domain that adopts a pseudo-knot-type structure consisting of a β-sheet fold bifurcated 
by an inserted region of variable size and structure, termed the iSET motif (Figure 1.4) 
(44, 45). AdoMet binds in a pocket with its methyl group protruding into a narrow pore. 
The protein substrate binds on the opposite face of the SET domain, with the lysine side 
chain of the protein substrate extending through a channel traversing the core of the 
protein, terminating at the AdoMet methyl transfer pore on the other side. This 
arrangement places the lysine ε-amine group and AdoMet methyl group into close 
proximity and in appropriate geometry for SN2 transfer (46). Among the 
methyltransferases in the SET domain family, SET7/9, which catalyzes lysine 
monomethylation in multiple sequence contexts, has emerged as a model system for 
study of these enzymes, as it was among the first of these enzymes to be structurally, 




Figure 1.4: SET domain architecture. 
SET domain in complex with product AdoHcy (red) and H3K9me1 peptide (yellow carbon atoms). 
Early structures from the Hurley and Trievel groups identified that the AdoMet 
methyl transfer pores of SET domain methyltransferases are curiously lined with 
oxygen atoms (Figure 1.5) (49, 56). This finding was unusual, as it was expected that as 
the methyl group is often considered a hydrophobic moiety, it would be found within a 
hydrophobic pore. The distances and positions of these oxygens relative to the AdoMet 
methyl group suggested that it may form unconventional CH···O hydrogen bonds with 
multiple oxygen atoms in the SET domain active site. These hydrogen bonds are still 
little known or understood in biology, but were hypothesized to aid in AdoMet binding 
as well as catalysis by stabilizing the SN2 transition state and aligning the electrophile 
for attack (49). Studying these interactions and how they are involved in methyl transfer 
has formed the bulk of my dissertation research. The following section introduces the 
concept of CH···O hydrogen bonding and its roles in biology to provide context for 




Figure 1.5: Oxygen-lined pore of SET domain methyltransferase. 
Lysine acceptor is depicted opposite AdoMet. 
1.2 CH···O Hydrogen Bonds in Biology 
1.2.1 Introduction and Historical Perspective 
Conventional hydrogen bonds (NH···O, OH···O, OH···N, and NH···N) represent 
fundamental stabilizing forces in biomolecular structure. Traditionally, carbon has not 
been considered a conventional hydrogen bond donor, due to its relatively low 
electronegativity compared to oxygen and nitrogen. However, several studies have 
illustrated that aliphatic carbon atoms are capable of forming weak hydrogen bonds, 
which are denoted as CH···O hydrogen bonds (57, 58). In contrast, with increased 
polarization due to adjacent atoms, carbons can theoretically participate in hydrogen 
bonds as strong as those formed by conventional donors, specifically oxygen or 
nitrogen (59, 60). 
Many authors have pointed out that it is difficult to define a hydrogen bond, as it 
is a class of interactions that exhibit varied properties and behavior. One useful 
definition posits that hydrogen bonding occurs between a proton donor group A-H, 
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where A can be any electronegative element, and an acceptor group that is either a lone 
pair of electrons or a π bond (61). In these interactions, the hydrogen is shared between 
the donor and acceptor to varying degrees, and charge transfer occurs across this bond. 
The extent of this sharing often dictates the properties of the hydrogen bond, leading to 
a wide range of hydrogen bond strengths and geometries. Experimental evaluation of 
hydrogen atom sharing in a biomolecular system is somewhat challenging, and 
furthermore, not all chemists and physicists agree that charge transfer is even a 
requirement for hydrogen bond formation (62). Hydrogen bonds are further 
distinguished from van der waals contacts by the presence of electrostatic attraction, 
which is not a requirement of the van der waals interaction that need only consist of 
dispersive attraction and exchange repulsion (63). Recently, The Union of Pure and 
Applied Chemistry (IUPAC) commissioned a task force to update the definition of the 
hydrogen bond. The resulting document very specifically addresses how a hydrogen 
bond is defined, and I refer the reader to it for details (64). The overarching theme of 
this new definition is that it provides a set of criteria (both theoretical and empirical) for 
evaluation of a particular interaction as to whether or not to consider it a hydrogen 
bond. As discussed in this document, there are many different means to identify a 
hydrogen bond, including using structural characteristics such as angles and distances 
that indicate hydrogen bond formation. This approach is especially useful in biological 
systems, for which many high-resolution crystal structures have been solved and 
provide a rich source of hydrogen bonding information. As such, within biochemistry 
and biophysics, it has become commonplace to use distance and angular criteria to 
define a hydrogen bond. 
Hydrogen bonds tend towards linearity and optimal overlap between the lone 
pair of the hydrogen bond acceptor and the hydrogen atom. Typically, the sharing of 
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the hydrogen atom and electrostatic attraction between the donor and acceptor allows 
them to encroach to within distances that would otherwise cause steric clashes. Thus, 
the most commonly used method for discovering hydrogen bond interactions is to 
examine the hydrogen bond length between the donor and acceptor groups (Figure 1.6). 
Distances that equal less than that of the sum of the atoms’ van der Waals radii often 
indicate hydrogen bond formation. Spectroscopic signatures can also be used to 
characterize hydrogen bonding. Analogous to conventional hydrogen bonds, CH···O 
bonds cause a substantial downfield 1H chemical shift change (65). In infrared (IR) 
spectroscopy, these interactions are unusual in that they usually cause a blue IR shift, 
indicative of C-H bond shortening, as opposed to the typical bond lengthening 
observed in conventional hydrogen bonds (66, 67). Despite this difference, the literature 
on this subject has reached a consensus that the CH···O interaction represents a bona-
fide hydrogen bond (68, 69).  
 
Figure 1.6: Distance and angular parameters used when defining CH···O hydrogen bonds. 
Typical van der Waals distances d (2.7 Å) and D (3.7 Å) are frequently used as distance cutoffs for 
hydrogen bond identification. 
The emergence of CH···O hydrogen bonding as an important interaction in 
biological structure and function stems from research dating back several decades. 
Although the first proposals of carbon-donor hydrogen bonding by Kumler (70) and 
12 
 
Glasstone (71) date to the mid-1930s (Figure 1.7), the first notable studies in proteins by 
Ramachandran (72, 73) and Krimm (66, 74) in the 1960s raised the possibility that these 
interactions contribute significantly to protein structure. In more recent work, 
Derewenda et al. (75) catalogued the ubiquitous nature of backbone Cα donor 
hydrogen bonds in proteins based on a survey of 13 high-resolution protein crystal 
structures, using methodology established by Taylor and Kennard in their landmark 
Cambridge Structural Database survey in 1982 (76). Using van der Waals distance 
cutoffs, Derewenda’s survey identified that a surprisingly high percentage of Cα···O 
contacts form CH···O hydrogen bonds in these proteins. The mean distance calculated 
for all C···O contacts in the interactions surveyed was 3.5 Å, well within the van der 
Waals distance cutoff of 3.7 Å (Figure 1.6). Using C···C interactions as a reference, they 
were able to clearly demonstrate the widespread nature of CH···O hydrogen bonding in 
proteins (Figure 1.8), especially in the standard backbone hydrogen bonding pattern of 
β-sheets. In addition, CH···O hydrogen bonding has been recognized in nucleic acids, 
dating back to early crystal structures that identified surprisingly close contact distances 
between purine C8 and pyrimidine C6 atoms, and phosphate backbone oxygen atoms 
(77). Since these early studies, many have endeavored to elucidate the breadth, scope, 




Figure 1.7: Timeline of important events in the history of CH···O hydrogen bonding research. 
The “Dark Years” period outlined in red refers to the years following Donohue’s rejection of the existence 
of CH···O hydrogen bonding (red flag), and before Taylor and Kennard’s landmark study confirming 
their existence. For a recount of this episode, please see Schwalbe’s review of the subject (78). 
1.2.2 Contributions to Protein Structure 
Characterization of CH···O hydrogen bonds in protein structure spans several 
decades (66, 72, 75, 79). The aforementioned study by Derewenda and colleagues has 
led to widespread acceptance of Cα-Hα···O=C hydrogen bonds, especially main chain 
interactions within β-sheet structures. More recently, X-ray crystallography and NMR 
spectroscopy have validated the existence of these interactions in proteins. A number of 
ultra-high resolution (<1.0 Å) X-ray structures have allowed direct visualization of 
hydrogen positions, permitting visualization of hydrogen bonding patterns within 
proteins. Many of these studies have attempted to define CH···O bonding patterns 
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within protein structures (80-82) and established unequivocal evidence for CH···O 
hydrogen bond formation in parallel and anti-parallel β-sheets. In fact, it was 
determined that the idealized position of Hα atoms in β-sheet structure was rarely 
observed, as the Hα was frequently displaced 0.2-0.3 Å away from its idealized position 
to increase its CH···O hydrogen bonding potential (82). These findings were further 
substantiated using NMR spectroscopy through scalar and quadrupolar coupling 
measurements. In 2003, Grzesiek and colleagues employed long-range scalar coupling 
experiments to examine Cα-Hα···O=C interactions in the immunoglobulin binding 
domain of protein G. In this study, the authors demonstrated that, analogous to 
conventional hydrogen bonds, magnetization could be transferred via scalar couplings 
across CH···O hydrogen bonds in the context of a folded protein, providing direct 
evidence of hydrogen bond formation (83). Other NMR evidence has more recently 
come from the measurement of Hα quadrupolar coupling constants. The measured 
constants in ubiquitin revealed variability in the quadrupolar coupling magnitude, and 
that the lowest set of couplings corresponded to residues that were predicted to form 
Cα-Hα···O=C bonds based on distance (84). As quadrupolar coupling constants are 
dictated by the shape of the electron density surrounding the nucleus of interest, the 
decreased quadrupolar coupling constant magnitudes were attributed to increased 
electronic symmetry due to hydrogen bonding. These studies have demonstrated with 
certainty that Cα-Hα···O=C hydrogen bonds are highly prevalent in protein structure, 
and should be considered a building block of secondary and tertiary structure. 
Beyond backbone interactions, there is also experimental evidence for CH···O 
hydrogen bonds involving amino acid side chains in protein structure. For example, 
histidine side chains have been implicated in CH···O hydrogen bonding (81, 85), and are 
predicted to form interactions as strong as conventional hydrogen bonds when the 
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imidazole group is protonated or bound to a metal ion (86). Additional evidence has 
emerged from neutron crystallography, an evolving technology that holds great 
promise for directly visualizing CH···O hydrogen bonds. Unlike X-rays, neutrons are 
diffracted by atomic nuclei, enabling complementary structural information, and most 
importantly, direct visualization of hydrogen or deuterium atom positions (87). Over 
the past decade, the number of neutron structures in the PDB has increased 
dramatically, providing many unprecedented snapshots of protein hydrogen bonding. 
Most notably, one recent study endeavored to analyze the prevalence of CH···O 
hydrogen bonding in amicyanin, a cupredoxin that binds copper in bacteria. By using 
joint X-ray and neutron refinement, the investigators were able to obtain a high-
resolution structure with excellent visualization of hydrogen atoms. By analyzing the 
hydrogen positions, the authors observed a remarkable 27 CH···O hydrogen bonds in 
the copper coordination site (Figure 1.8) in addition to eight conventional hydrogen 
bonds (88). As neutron crystallography evolves, unconventional interactions will likely 
become more accepted as there are observed more commonly in high-resolution 
structures. 
 
Figure 1.8 Examples of CH···O hydrogen bonds (orange dashes) in proteins. 
(A) Typical hydrogen bonding pattern in β-sheet (82). Extensive CH···O hydrogen bonding in (B) packed 
α-helices (89) and (C) the copper coordination site in amicyanin (88). 
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1.2.3 CH···O Hydrogen Bonding in Nucleic Acid Structures 
 Although many recent advances in understanding CH···O hydrogen bonding 
have arisen from studies of protein structure, these interactions have long been 
appreciated in nucleic acid structure. In early crystal structures of single nucleotides, it 
was noted that multiple CH···O hydrogen bonds were apparent, especially between 
phosphate backbone oxygens and the C6 atom of pyrimidines and the C8 atom of 
purines, and that these interactions were likely stabilized by the anti conformation (90, 
91). NMR and Raman spectroscopy later corroborated the claim that the acidity of the 
C8 atom in purine rings poises it for CH···O hydrogen bonding in RNA duplexes (92). 
Finally, a survey of high-resolution RNA structures (<2.0 Å) illustrated that short 
CH···O contacts are ubiquitous and appear to stabilize RNA tertiary structure (93). 
Despite these crystallographic findings and multiple studies implicating CH···O 
hydrogen bond formation in nucleic acids (94-97), the quantity of direct evidence of 
CH···O hydrogen bonding in nucleic acids is comparatively smaller than that in 
proteins. In part, this dearth is due to a general lack of neutron or high-resolution X-ray 
crystal structures of RNA. Of those few RNA structures solved to sufficiently high 
resolution to visualize hydrogen atoms (<1.0 Å), only in one study of an RNA tetraplex 
do the authors explore the possibility of CH···O hydrogen bonding (Figure 1.9) (98). 
However, this structure, does not address many common RNA secondary and tertiary 
structural elements. Although the formation of CH···O hydrogen bonds in A-T base 
pairs, both in Watson-Crick and Hoogsteen conformation, have been debated in the 
literature (99-102), experiments have yet to definitively resolve whether these 
interactions represent true hydrogen bonds that stabilize DNA and RNA structure. 
Corollary studies to those in proteins aimed at directly probing CH···O hydrogen bond 
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formation in base pairs, backbone interactions, and tertiary structure represent a 
promising area of future research. 
 
Figure 1.9: Examples of CH···O hydrogen bonds (orange dashes) in nucleic acids. 
(A) Hydrogen bonding patterns in Watson-Crick (top) and Hoogsteen (bottom) adenine-thymidine base 
pairs. Extensive CH···O hydrogen bonding in (B) DNA i-motif (103) and (C) RNA tetraplex (98). 
1.2.4 CH···O Hydrogen Bonding in Molecular Recognition 
Evidence and importance of CH···O hydrogen bonding to molecular recognition 
is also a current focus of research. These hydrogen bonds have been implicated in many 
intermolecular interactions, including those involving proteinprotein, proteinligand, 
and proteinnucleic acid complexes. Although relatively few studies have analyzed 
CH···O hydrogen bonding in proteinprotein complexes, a recently determined X-ray 
structure at 0.9 Å resolution of the ATRX ADD domain bound to a histone H3 peptide 
bearing a trimethylated Lys-9 in which the methyl hydrogen density is clearly visible 
illustrates that the lysine trimethylammonium cation is specifically recognized through 
a network of methyl CH···O hydrogen bonds (104) (Figure 1.10). Similarly, in a recently 
determined neutron structure of transthyretin, the authors noted that that the ratio of 
CH···O to conventional hydrogen bonds in the interface between the A and D subunits 




Figure 1.10: Examples of CH···O hydrogen bonds (orange dashes) in molecular recognition and enzyme 
catalysis. 
(A) Recognition of trimethyllysine by CH···O hydrogen bonds in the ATRX ADD domain (41). (B) 
Schematic depiction of 234TMT (upper) and 345TMT (lower) binding to an engineered protein active site 
(106). (C) Conserved serine hydrolase CH···O hydrogen bond between the catalytic histidine and serine 
residues (107). 
With respect to proteinligand binding, Klaholz et al. was among the first to use 
X-ray crystallography to analyze the nuclear receptor RARγ bound to retinoid SR11254 
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to identify CH···O hydrogen bonds involved in ligand recognition. Along with several 
proteinprotein CH···O interactions, they discovered numerous CH···O bonds between 
different moieties of the ligand with hydrogen bond donors and acceptors at several 
different positions, suggesting that multiple CH···O interactions may significantly 
contribute to ligand binding affinity (108). Similar to neutron studies of proteinprotein 
interactions, neutron diffraction studies also have provided evidence for these 
interactions between proteins and water and ligand molecules.For example, in the 
neutron structure of xylulose-isomerase, a CH···O hydrogen bond between the protein 
His220 C1 and O2 of xylulose may facilitate xylulose recognition (109). To address the 
possibility of proteinsolvent CH···O bonds, one neutron crystallographic study 
analyzed the proteinsolvent interface of lysozyme. Surprisingly, large sections of its 
surface interacted with water exclusively through CH···O hydrogen bonding (110), 
suggesting important roles for these interactions in protein solubility and folding.  
Protein-nucleic acid recognition is fundamental to myriad biological processes, 
particularly those involving DNA transactions. Due to the relatively fixed nature of the 
DNA duplex, both conventional and CH···O hydrogen bonding interactions are formed 
in concert in relatively predictable patterns. In a survey of proteinDNA crystal 
structures, it was found that thymine and cytosine appear to consistently form CH···O 
hydrogen bonds when in complex (111). In total, the distribution of C···O distances in 
nucleic acid/protein complexes was more consistent with conventional N···O hydrogen 
bond distances than that of control C···C distributions. Interestingly, the thymine 
methyl group is the most frequent CH···O hydrogen bond donor, in spite of its lower 
polarization compared to the nucleobase aromatic carbon atoms. Despite the promising 
nature of this early work, more neutron and ultra-high resolution X-ray structures that 
specifically probe the importance and nature of CH···O hydrogen bonds in 
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protein/nucleic acid complexes are required. Determining the importance and function 
of CH···O hydrogen bonds in protein/nucleic acid complexes remains an exciting future 
avenue of research. 
1.2.5 Measurement of CH···O Hydrogen Bond Strength  
Although obtaining evidence of CH···O hydrogen bond formation in 
biomolecular structures is informative, it does not address the strength or biological 
importance of these interactions. Much of the insight gained thus far on the relevance of 
these interactions derives from computational studies of the relative strengths of CH···O 
bonds in protein structures (59, 112). These studies have generally shown CH···O bonds 
to be weak interactions, typically exhibiting half the bond energy of a conventional 
hydrogen bond in gas phase calculations. However, it is noteworthy that these studies 
have consistently found that not only are these interactions fundamental in protein 
structure, but in some instances can be as strong as conventional hydrogen bonds (59). 
In one striking example, it was estimated that 17% of all proteinprotein surface 
interaction energy arises from CH···O hydrogen bonding, and that in some extreme 
cases this percentage can be as high as 40-50% (113). Although CH···O hydrogen bonds 
are often weak, they frequently occur in greater quantities than their conventional 
counterparts and thus may contribute significantly to proteinprotein interaction 
energies. 
In addition to a solid computational foundation, a few studies have provided 
direct experimental evidence of CH···O hydrogen bond strength and importance in 
proteins. Using a combination of high-pressure infrared spectroscopy and X-ray 
crystallography, CH···O bonds were found to be crucial in artificial β-sheet-like network 
formation (114), and it is possible that these interactions are of similar importance in 
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true β-sheets. In a contrasting example, Bowie et al. determined that a Cα-Hα···O 
hydrogen bond in bacteriorhodopsin did not provide any stabilization protein 
stabilization energy (115), although subsequent studies demonstrated that conventional 
hydrogen bonding in bacteriorhodopsin was also surprisingly weak (116). In contrast, a 
separate concurrent study using infrared spectroscopy discovered a substantially 
stronger protein CH···O hydrogen bond, = 0.9 kcal/mol, comparable to a weak 
conventional hydrogen bond in a protein environment (79). Correlatively, Kallenbach et 
al. analyzed helical peptides using circular dichroism to show that a single CH···O 
hydrogen bond contributed ~0.5 kcal/mol of helix stabilization energy, but only with 
certain side chain sequences and orientations (117). Thus, from experimental evidence, 
the exact energetic stabilization contributed by CH···O hydrogen bonds to protein 
folding remains ambiguous. As in the case of conventional interactions, the contribution 
of a single CH···O hydrogen bond to protein stabilization depends on its hybridization 
and polarization as well as its role and position in protein folding (118). Further studies 
are needed to precisely define the energetic values of CH···O hydrogen bonds and their 
contributions to protein folding.  
In comparison to the foregoing examples, relatively few studies have 
experimentally explored CH···O hydrogen bond strengths in proteinligand binding. 
One notable exception is a study that analyzed the binding of two related compounds, 
2,3,4-trimethylthiazole (234TMT) and 3,4,5-trimethylthiazole (345TMT), to a cytochrome 
c peroxidase mutant (Figure 1.10). These compounds are both cationic, containing a 
formal positive charge on the nitrogen atom. The only difference between them 
involves the relative placement of the nitrogen in the aromatic ring system. These 
nitrogens are methylated and thus cannot directly participate in hydrogen bonding. 
However, a single carbon atom in the aromatic ring in each compound is in appropriate 
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geometry to form a CH···O hydrogen bond to Asp235 in the enzyme. The only 
difference between these two molecules is that in 234TMT, the nitrogen is two positions 
removed from this hydrogen bonded C-H group, whereas in 345TMT, it is only one 
position removed, similar to histidine residues. Due to the proximity of the positively 
charged nitrogen to the CH···O hydrogen bond that should enhance the carbon 
polarization, 345TMT was computationally predicted to form a substantially stronger 
CH···O bond than 234TMT, accounting for the difference in binding energy between the 
two ligands. By solving crystal structures of the two complexes, the authors verified 
that the ligand binding modes were essentially identical (Figure 1.10). Upon measuring 
the binding constants for each ligand, the authors determined that the binding energy 
of 345TMT was 1.2 kcal/mol greater than that of 234TMT (106), substantiating their 
computational predictions.  
Within nucleic acids, the CH···O hydrogen bonding strength within the i-motif 
has undergone uniquely in-depth study. This motif is a quadruplex-like structure 
consisting of four strands containing intercalated C.CH+ base pairs and linked loops 
(Figure 1.9) that may form at the end of telomeres (119). Initial structures of this motif 
revealed extensive CH···O hydrogen bond networks, suggesting that these interactions 
may promote i-motif formation (120, 121). To substantiate these observations, Gueron et 
al. attempted to determine the average strength of C1´ CH···O bonds using different 
intercalation topologies that a single sequence could form as a function of ionic strength 
and temperature (121). Based on these experiments, an average C1´···O hydrogen bond 
strength was measured to be 0.6 kcal/mol. Cumulatively, these interactions likely 
contribute significant stabilization energy in the i-motif. 
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Given their prevalence in proteins, it is likely that CH···O hydrogen bonding 
contributes substantially to the specificity of RNA folding. Indeed, these interactions 
have recently been introduced as a parameter in RNA tertiary structure predictions 
(122), but have yet to be experimentally evaluated. Similarly, determining what, if any, 
contribution CH···O hydrogen bonding plays in DNA base pairing would expand our 
understanding of their energetic contributions in both base-pair separation and 
formation in processes such as transcription, and DNA replication, repair, and 
recombination. Finally, the ~1 kcal/mol hydrogen bond found by Arbely et al. is similar 
in strength to that determined by the previous study of 345TMT, supporting the notion 
that these interactions are not only important in protein structure and folding, but also 
in ligand binding.  
1.2.6 CH···O Hydrogen Bonding in Enzyme Catalysis 
In addition to macromolecular structure, CH···O hydrogen bonds have been 
implicated either directly or indirectly in the catalytic mechanisms of several classes of 
enzymes. One well studied case is serine hydrolases bearing a His-Asp(Glu)-Ser 
catalytic triad, including but not limited to serine proteases, lipases, and thioesterases. 
An early survey of these enzymes by Derewenda et al. identified short histidine-oxygen 
distances between the catalytic histidine C1 and an adjacent carbonyl oxygen that were 
indicative of CH···O hydrogen bonding (123). This hydrogen bond was proposed to 
stabilize the imidazolium cation and to potentially facilitate a ring-flipping mechanism 
(85, 123). Derewenda’s observation was further supported by Bachovchin et al., who 
used NMR chemical shift to show that the downfield chemical shift of the histidine H1 
proton was consistent with CH···O hydrogen bonding (85). Corroboratively, Hunter et 
al. proposed based on crystallographic distances that a CH···O bond formed between 
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the catalytic triad histidine and a substrate carbonyl group in trypanothione reductase 
would presumably stabilize the positive charge formed on the histidine side-chain, 
facilitating an electronically induced fit mechanism (124). 
CH···O hydrogen bonding has also been implicated in enzyme acid-base 
catalyzed reactions involving carbon atoms. Typically, proton abstraction is preceded 
by hydrogen bond formation. In the case of proton abstraction from a carbon, a CH···O 
hydrogen bond would therefore be formed prior to proton transfer. For example, in 
acyl-CoA dehydrogenases, the initial step of catalysis involves proton abstraction from 
the Cα atom of the acyl-CoA substrate by a glutamate base. The reaction was 
investigated computationally (125), indicating that a strong ionic CH···O hydrogen bond 
forms along the reaction coordinate prior to proton abstraction from the Cα position in 
the acyl chain. Given the ubiquitous nature of acid-base chemistry in enzyme catalysis, 
this reaction constitutes a mechanism of particular interest for future experimental 
investigation that will likely uncover addition roles for CH···O hydrogen bonding in 
many enzyme mechanisms. 
 Recent studies have also identified functions for CH···O hydrogen bonding in 
lysine demethylation and methylation reactions. CH···O hydrogen bonds appear to be 
important in methyllysine binding both by SET domain methyltransferases and 
Jumonji-C (JmjC) lysine demethylases (KDMs), analogous to the ATRX ADD domain 
Figure 1.10.In the JmjC KDM JMJD2A, mutational and structural evidence suggest that 
CH···O hydrogen bonds are important in distinguishing between di- and trimethylated 
lysine. These interactions have also been reported in other JmjC KDMS, including UTX 
(126), PHF8 (127) and JMJD3 (128). 
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Structural and functional studies of the lysine methyltransferases belonging to 
the SET domain family revealed that AdoMet methyl CH···O hydrogen bonds are 
conserved in these enzymes, indicating a potential role in cofactor binding and catalysis 
(49) (Figure 1.11). These hydrogen bonds could potentially be strong interactions due to 
the electron withdrawing character of the sulfonium cation, polarizing the methyl 
group of AdoMet. Isothermal calorimetry demonstrated that AdoMet displays higher 
binding affinity to a SET domain methyltransferase than AdoMet analogues that are 
incapable of forming CH···O hydrogen bonds (49), suggesting the importance of these 
interactions in substrate binding. It was hypothesized that these interactions not only 
aid in AdoMet recognition, but also in transition state stabilization by selectively 
binding to the partially positively charged sp2 carbon in the SN2 transition state. In 
addition, structural and mutagenic data indicated that CH···O hydrogen bonds are 
important for the repositioning of the ε-amine group to enable lysine multiple 
methylation (129, 130). Together, these studies suggested that CH···O hydrogen bonds 





Figure 1.11: Crystal structure of SET7/9 bound to AdoMet (47, 49). 
This figure was originally published in The Journal of Biological Chemistry (49) © the American Society 
for Biochemistry and Molecular Biology. 
1.3 Objectives of this Dissertation 
Despite many recent discoveries pertaining to CH···O hydrogen bonding in 
biology, to our knowledge, no studies have experimentally demonstrated that CH···O 
hydrogen bonds are vital to any core biological process. Using AdoMet-dependent 
methylation as a case study, I intended to directly test whether CH···O hydrogen bonds 
are fundamentally required for cofactor binding or catalysis in these enzymes. In this 
dissertation I aim to answer three major questions about the role of CH···O hydrogen 
bonding in methyl transfer: 1) Do these CH···O hydrogen bonds exist in the 
methyltransferase active site? 2) Are they important for cofactor binding or catalysis? 
And 3) How do these interactions facilitate cofactor binding and/or catalysis? 
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: Direct Evidence for Methyl Group Coordination by CH···O Hydrogen Chapter 2
Bonds in SET Domain Methyltransferases 
2.1 Objective and Approach 
As discussed in Chapter 1, CH···O hydrogen bonding has been recognized as an 
important interaction in proteins and other biological macromolecules dating back over 
40 years (74, 131-133). Despite their potential importance, experimental characterization 
of CH···O hydrogen bonds in proteins remains challenging. Current methods for 
identifying CH···O hydrogen bonds (83, 84, 88) are difficult to employ for many 
proteins, including SET7/9. However, NMR spectroscopy holds promise in identifying 
CH···O hydrogen bonds in proteins and other macromolecules via 1H chemical shift (67, 
85, 134). Chemical shift is a sensitive probe of electronic environment. The 1H nucleus is 
especially sensitive to hydrogen bonding (65), as a distinctive downfield chemical shift 
change accompanies hydrogen bond formation. This change is thought to arise from 
charge transfer to the hydrogen atom, a property unique to hydrogen bonding that 
dominates the chemical shift effects of other forces present in many types of interactions 
(135). Using this property, Bachovchin et al. were able to qualitatively confirm that the 
histidine H1 in serine proteases forms a CH···O hydrogen bond, as discussed in Chapter 
1. More recently, it was proposed that CH···O bonds in biomolecules could be detected 
quantitatively by combining  1H chemical shift measurements with DFT computations 
(67). The feasibility of this approach was recently demonstrated by using a similar 
strategy to discover CH···S hydrogen bonds to a protein iron sulfur cluster (136). 
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As previously mentioned, CH···O hydrogen bonding in SET domain 
methyltransferases were identified in X-ray crystal structures, in which C···O distances 
between the AdoMet methyl carbon and structurally conserved carbonyl oxygen atoms 
and an invariant tyrosine were appropriate (less than 3.7 Å) for CH···O hydrogen 
bonding to occur (49) (Figure 1.11). In addition, it was postulated that the CH···O 
hydrogen bonds align the AdoMet methyl group in the requisite linear geometry with 
the substrate lysine ε-amine group for the SN2 methyl transfer reaction. (Figure 1.5) (48, 
49, 137-139). However, as hydrogen atoms are not observed in all but the highest 
resolution X-ray crystal structures, it is possible that the AdoMet methyl protons 
occupy positions that preclude CH···O hydrogen bond formation, despite close C···O 
contacts within SET domain crystal structures. Thus, the presence of CH···O hydrogen 
bonding can only be inferred from these structures. The fundamental question we 
address here: Is there direct experimental evidence for CH···O hydrogen bonding 
between the AdoMet methyl group and the SET domain active site in solution? 
2.2 Materials and Methods 
2.2.1 Expression and purification of MetK and SET7/9 
A plasmid encoding the AdoMet synthetase (MetK) gene from Methanococcus 
jannaschii was generously provided by George D. Markham. The gene was subcloned 
into pHT4, a variant on the pET15b vector (Novagen) that contains an N-terminal 6x-
His tag with a TEV protease cleavage site to facilitate protein purification. MetK was 
expressed in E. coli BL21 DE3 cells grown in LB media by induction with 0.1 mM 
isopropylthiogalactoside for 4 hours at 37°. The enzyme was purified on a Talon Co 
affinity column (Clontech) followed by Superdex 200 (GE Healthcare) gel filtration 
chromatography. Following gel filtration, MetK was concentrated to approximately 20 
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mg/mL as determined by its absorbance at 280 nm, flash frozen in liquid nitrogen, and 
stored at -80o C. 
SET7/9 (residues 110-366) was expressed and purified as previously described 
(140), with the following exceptions. The enzyme was purified by denaturation and 
refolding while immobilized on a Ni-Sepharose column (GE healthcare). SET7/9 was 
unfolded by washing the column with 7-10 column volumes of 6M guanidinium 
chloride, refolded with a gradient into the lysis buffer, and subsequently eluted using 
an imidazole gradient. The denaturation and refolding protocol were necessary to 
remove AdoMet that can co-purify with the recombinant enzyme expressed in bacteria 
(140). After gel filtration chromatography, SET7/9 was concentrated to at least 40 
mg/mL as determined by its absorbance at 280 nm, flash-frozen, and stored at -80o C. 
2.2.2 Synthesis and purification of AdoMet 
13C-methyl AdoMet was enzymatically synthesized from ATP and 13C-methyl L-
methionine (Sigma) using MetK as previously described (141) with the following 
modifications. Reactions were performed in final volume of 5 mL for 5 hours at 298 K. 
At the end of the reaction, AdoMet was purified using a Source 15S column (GE 
Healthcare), as previously described (142). The purity of the resulting AdoMet was 
verified by NMR and estimated to be approximately 95% pure. Existing impurities 
showed neither chemical shift change nor intensity change upon addition of 13C-methyl 
AdoMet to SET7/9. 
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2.2.3 Molecular dynamics (MD) simulation and quantum chemistry calculations of 
AdoMet in water 
In order to accurately quantify the chemical shift of the AdoMet methyl group in 
water, we first determined the number hydrogen bonds formed by the AdoMet methyl 
group in water, followed by quantum chemical calculations of the AdoMet methyl 
group’s chemical shift. The starting structure for the MD simulation was derived from a 
B3LYP/6-311+G(2d,p) optimized AdoMet structure. Partial charges were assigned to the 
starting AdoMet structure using a B3LYP/6-311+G(2d,p) CHELP calculation (143). All 
density functional theory (DFT) computations were accomplished using Gaussian 03 
(144). The MD simulation was run using the CHARMM36 forcefield (145) in (35.2 x 25.5 
x 22.2) Å TIP3P water box (146) for 10 ns, using a 2 fs timestep. The simulation was 
conducted at 298K using a Nose-Hoover Thermostat (147) using periodic boundary 
conditions conducted using the particle mesh Ewald method (148). Other AdoMet 
(bond, angle, dihedral) parameters derived from the CHARMM General Force Field 
parameter set (149). Analysis of the MD trajectory in 20 fs steps revealed that the 
AdoMet methyl group forms, on average, 0.36 hydrogen bonds in solution per methyl 
group. Therefore, to correctly model the solution state of the AdoMet methyl group, one 
weak CH···O hydrogen bond was included in the chemical shift calculations. 
The coordinates of the aqueous AdoMet solution structure were provided by 
George D. Markham (150). The methyl proton geometry was optimized using B3LYP/6-
311+G(2d,p) (151, 152) with implicit water solvation by the Polarizable Continuum 
Model (153) with all other atoms frozen. The optimized geometry of the AdoMet methyl 
group formed one intra-molecular CH···O hydrogen bond with the ribose 3´-hydroxyl 
group (Figure 2.2). The geometry of this interaction (C-H-O angle = 131° and H···O 
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interaction distance = 2.5 Å) was consistent with a weak hydrogen bond. Thus, this 
interaction satisfied our condition to include one weak CH···O hydrogen bond in the 
quantum chemistry calculations to correctly represent AdoMet in water, as determined 
by the MD simulation described above. Chemical shifts were calculated using the 
Gauge Independent Atomic Orbitals (154) method in implicit water for the reasons 
described above. The chemical shift of the AdoMet methyl group in this conformation 
yielded a chemical shift of 3.0 ppm, well within 0.1 ppm of experiment. Breaking the 
CH···O hydrogen bond by rotating the AdoMet methyl group yielded a chemical shift 
of 2.9 ppm, confirming that the suboptimal geometry of the hydrogen bond resulted in 
a weak interaction (155). As a reference, tetramethylsilane was optimized in implicit 
water and chemical shifts were calculated with the same methods as above.  
2.2.4 Quantum chemistry calculations on the SET7/9AdoMet complex 
The model SET7/9 active site included all atoms within 5 Å of the AdoMet 
methyl group from the SET7/9AdoMet binary complex (47). The AdoMet molecule 
was truncated at the carbon positions adjacent to the sulfonium cation. Protons were 
added automatically using Chimera (156), and a single chlorine atom was placed in the 
position of the AdoMet carboxylic acid group to neutralize the system. All added 
hydrogen positions were optimized using B3LYP/3-21G* (157, 158), and methyl protons 
were subsequently optimized and chemical shifts calculated with B3LYP/6-311+G(2d,p) 
as described for free AdoMet. Using implicit solvent with a lower dielectric constant to 
reflect the hydrophobic core of proteins (ε=4.9) for chemical shift calculations yielded no 
change in 1H chemical shift of the AdoMet methyl group as compared to implicit water 
solvation. Figures were rendered in PyMol (Schrödinger LLC). All calculated and 
measured chemical shifts are shown in Table S1. Methyl rotamers for chemical shift 
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calculations were created by manually rotating the AdoMet methyl group. Structural 
figures were rendered using PyMOL (Schrödinger, LLC). 
2.2.5 NMR spectroscopy 
All NMR experiments were performed on a 600 MHz Avance Bruker NMR 
spectrometer equipped with a triple resonance cryoprobe at 298 K. Spectra were 
referenced using the water signal. Data was processed and analyzed using 
NMRPipe/NMRDraw, and Sparky, respectively (159, 160). The AdoMet methyl group’s 
assignment was confirmed by recording control 13C 2D- Heteronuclear Single Quantum 
Coherence (HSQC) spectra of three separate samples: SET7/9 with no added AdoMet, 
SET7/9 plus stoichiometric quantities of unlabeled AdoMet, and 13C-AdoMet with no 
added SET7/9. The resonance assigned as the bound AdoMet methyl group was not 
present in any of these three control spectra, whereas it was apparent in the 13C-methyl-
AdoMet•SET7/9 sample. Upon addition of slight stoichiometric excess of SET7/9 to 13C-
labeled AdoMet, the peak corresponding to the free AdoMet 13C-methyl group 
completely shifted to the enzyme bound-peak in the 2D-HSQC spectrum, indicating 
that the AdoMet was fully saturated by the enzyme. Spectral overlays of SET7/9 in 
cofactor bound and free states were previously reported (51, 52). 
2.2.6 Isothermal Titration Calorimetry (ITC) 
ITC experiments were performed using a Microcal VP-ITC (GE Healthcare). All 
experiments were performed at 293 K in 20 mM Sodium Phosphate, pH=7.0 and 100 
mM sodium chloride. Varying concentrations of ligand (0.07-7.7 mM) and protein 
(0.006-0.193 mM) were used due to the large range of binding constants measured. Data 
analysis was accomplished using Microcal Origin (GE Healthcare). All binding curves 
had N-values between 0.8-1.0. Errors reported in Table 1 are from curve fitting errors. 
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Previous crystallographic studies have shown that the binding modes of AdoMet, 
Sinefungin and S-adenosylhomocysteine (AdoHcy) to SET7/9 are highly homologous 
(Figure 2.5). 
2.3 Results 
To probe CH···O hydrogen bonding between SET7/9 and the AdoMet methyl 
group, we examined the NMR chemical shift produced by the AdoMet methyl group 
while bound to SET7/9. To measure the bound 1H chemical shift for the AdoMet methyl 
group and distinguish it from resonances arising from the enzyme, we synthesized 13C-
methyl labeled AdoMet using AdoMet synthase and 13C-methyl-methioine (141, 161, 
162). We recorded 2D-HSQC spectra of 13C-methyl-AdoMet in the presence of 
stoichiometric quantities of the unlabeled catalytic domain of SET7/9 (Figure 2.1). The 
1H chemical shift of the AdoMet methyl group was recorded as 3.8 ppm. This chemical 
shift was unusually far downfield for a methyl group and also represented a large 
downfield change relative to the reported chemical shift for AdoMet methyl group free 
in solution (3.0 ppm) (163). Unlike 13C, downfield 1H chemical shift changes often 
qualitatively indicate hydrogen bond formation (65, 85, 135, 164, 165), thus we sought to 
verify our experimental chemical shift change using quantum chemistry calculations. 
While this combination of techniques has been used to identify CH···O hydrogen bonds 
in small organic molecules (134, 166, 167) and in computational biology (65), it has to 
our knowledge not yet been applied experimentally in biological macromolecules. 
Using this combination of techniques, we reasoned that it should be possible to solve 
for the hydrogen positions, and thus hydrogen bonding patterns, of the AdoMet methyl 




Figure 2.1: 2D-HSQC of SET7/913C-methyl AdoMet complex 
Previous studies of CH···O hydrogen bonding in small organic molecules show 
that the chemical shift calculations of hydrogen were usually accurate to 0.1 ppm of 
experiment (134, 166, 167). Error in biological molecules could arise from many sources, 
including but not limited to implicit solvation modeling and large or truncated 
molecules used in calculations. Therefore, to validate the accuracy of our calculations 
for the AdoMet methyl group, we first calculated the chemical shift of the AdoMet 
methyl group using the solution state NMR structure of free AdoMet in water. Methyl 
proton geometry was optimized, allowing for the appropriate number of hydrogen 
bonds formed in solution by the methyl group, followed by chemical shift calculation. 
By averaging all three values together to reproduce the single experimental methyl 
peak, the difference in chemical shift between the experimental (3.0 ppm) (163) and 
calculated values was less than 0.1 ppm. This level of accuracy prompted us to attempt 




Figure 2.2: Free AdoMet in implicit solvent. 
The CH···O hydrogen bond is shown in magenta. 
To compare with our experimental data, we then modeled the active site of 
SET7/9 using its crystal structure bound to AdoMet at 1.7 Å resolution (47). Hydrogens 
were added to this model, and the geometry of the hydrogen positions was optimized 
(see Chapter 2.2 for details). Chemical shifts were then calculated for the methyl group 
protons and averaged to a single value, as performed for free AdoMet. The geometry-
optimized structure of the AdoMet methyl group shows CH···O hydrogen bond 
formation from the AdoMet methyl group to the hydroxyl group of Tyr335 and main 
chain carbonyl oxygen of His-293, with H···O distances of 2.5 and 2.1 Å, respectively 
(Figure 2.3). Moreover, the C-H···O angles of 146° and 140°, respectively, were 
acceptable hydrogen bonding angles (132, 133, 168). As predicted, the calculations 
showed that protons participating in CH···O hydrogen bonds experienced significant 
downfield changes in chemical shift. The proton engaged in close hydrogen bonding 
with His-293 had a calculated chemical shift of 5.0 ppm, while the proton forming 
hydrogen bonds with Tyr335 had a calculated chemical shift of 3.3 ppm. The third 




together yielded a calculated chemical shift of 3.7 ppm, which is within 0.1 ppm of the 
experimental value of 3.8 ppm. 
 
Figure 2.3: Optimized and broken CH···O hydrogen bonds in SET7/9. 
(A) Optimized active site with bound AdoMet and (B) manually rotated geometry to eliminate CH···O 
hydrogen bonds. Truncated AdoMet and the protein are depicted with green and gray carbon atoms, 
respectively. Residues labeled in red designate CH···O acceptors 
To further confirm the presence of CH···O hydrogen bonding, the methyl group 
was manually rotated through a range of 120° (example shown in Figure 2.3), and 
chemical shifts recalculated at intermediate geometries to explore whether alternative 
hydrogen positions could agree with the experimental data. The rotation of the AdoMet 
methyl group resulted in a smooth functional change in the calculated chemical shift, 
passing through a minimum at 36° (Figure 2.4). The minimum of this plot corresponded 
to the structure for which the model and the experimentally measured shift differ by 0.6 
ppm. This difference represented: 1) the largest deviation between the experiment and 
model, 2) the most upfield of the calculated chemical shifts, and 3) the model in which 
the methyl rotamer formed minimal CH···O hydrogen bonds in the active site (Figure 
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2.3). These calculations indicated that AdoMet methyl rotamers precluding CH···O 
hydrogen bond formation were inconsistent with the experimental chemical shift data. 
All of the calculated chemical shifts that agreed closely with experimental chemical 
shifts represented structures that optimized CH···O hydrogen bonding for at least one 
AdoMet methyl hydrogen atom. Collectively, the experimental data and calculations 
yield direct evidence via NMR chemical shift for CH···O hydrogen bond formation 
between the AdoMet methyl group and oxygen atoms within the active site of SET7/9. 
 
Figure 2.4: Chemical shift of the AdoMet methyl group as a function of rotation angle. 
0° and 120°, rendered in green, are equivalent geometry optimized positions (displayed in Figure 2.3), 
whereas all other points were derived from manual rotation of the AdoMet methyl 
These findings prompted us to examine the thermodynamic parameters for 
cofactor binding by SET7/9 using ITC. Binding affinities and enthalpies for SET7/9 were 
measured with AdoMet (Figure 2.6), its methyl transfer product AdoHcy, and 
Sinefungin, an AdoMet analog in which the methyl-sulfonium cation is substituted by 
an amine-methylene group that can participate in conventional NH···O hydrogen 
bonding. Crystal structures of SET7/9 and other SET domain enzymes illustrated that 
these cofactors share a structurally homologous binding mode (Figure 2.5) (47, 48, 50). 
The ITC data revealed that SET7/9 displayed nanomolar affinities for AdoMet and 
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Sinefungin, whereas its affinity for AdoHcy was ~1000-fold weaker (Table 1). These 
data were analogous to those obtained for the binding of these ligands to the SET 
domain protein Rubisco large subunit methyltransferase (LSMT), demonstrating 
consistency in rank order of binding affinities across different SET domain enzymes 
(49). In addition, SET7/9 and LSMT displayed comparable differences in binding 
enthalpy between AdoMet and Sinefungin (~3 kcal/mol). The high affinity that these 
enzymes displayed for AdoMet is presumably due to the ability of its methyl group to 
engage in CH···O hydrogen bonding, emphasizing the importance of these interactions 





Figure 2.5: Binding modes of AdoMet (A), Sinefungin (B), and AdoHcy (C) to SET7/9 are nearly identical. 
Figures were rendered from PDB codes 1N6A (47), 3CBP (50) and 2F69 (169), respectively. Cofactor 
carbon atoms are rendered in green, and protein residues are rendered in gray. For clarity, some 
backbone atoms and side chains have been removed. The residues that can engage in CH···O hydrogen 




Figure 2.6: ITC analysis of AdoMet binding to SET7/9. 
The top panel represents the titration of AdoMet into SET7/9, while the bottom panel represents the 
binding isotherm with fitted curve. 





The identification of CH···O hydrogen bonding between a methyl group and 
oxygen atoms within the SET domain active site has implications for these interactions 
in lysine methyl transfer reactions. As previously proposed, CH···O hydrogen bonds 
appear to play roles in binding AdoMet, positioning its methyl group in an appropriate 
Ligand KD ΔH 
 nM kcal/mol 
AdoMet 53  ± 3 -26.7  ± 0.1 
Sinefungin 330   ± 24 -23.0  ± 0.2 
AdoHcy 60000   ± 5000 -24.4  ± 1.2 
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geometry for transfer, and stabilizing the SN2 transition state (49). These data suggest 
that the CH···O hydrogen bonds confer a specific orientation for the methyl group to 
align it during catalysis and could potentially limit its motion within the active site. 
The thermodynamic analyses of SET7/9 bound to AdoMet and its analogues are 
consistent with previous findings on LSMT (49). The consistency of rank order in 
binding affinity indicates that CH···O hydrogen bonds are important in cofactor binding 
by multiple methyltransferases due to the structural conservation of the SET domain 
active site. Moreover, these CH···O interactions may in part explain the importance of 
the evolutionarily invariant Tyr335 to enzyme function, given the propensity of its 
hydroxyl group to form CH···O hydrogen bonds with the AdoMet methyl group. It is 
also interesting to note that the change in binding affinity between AdoMet and its 
analogues is substantially more dramatic in SET7/9 than in LSMT. This effect could be a 
function of the plasticity of the SET7/9 active site (52), as compared to the preformed 
active site of LSMT (170). Future studies will need to address how conformational 
flexibility within the SET domain family influences CH···O hydrogen bonding to 
AdoMet. 
In terms of methodology, our results have demonstrated that chemical shift can be 
used as a structural parameter for determining hydrogen positions and hydrogen 
bonding patterns within an enzyme active site. To our knowledge, these chemical shift 
data and computations provide the first direct, quantitative evidence of CH···O 
hydrogen bonding in an enzyme active site in solution. One advantage of chemical shift 
as a probe to examine CH···O hydrogen bonding in biomolecular structure is the 
relative ease of data acquisition. In the future, this methodology could be broadly 
applied to characterize CH···O hydrogen bonding in proteins, nucleic acids, and other 
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biological molecules, expanding our understanding of the functional importance of 
these interactions in macromolecular structure, ligand binding, and enzyme catalysis. 
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: CH···O Hydrogen Bonds Mediate AdoMet-Dependent Methylation Chapter 3
3.1 Objective and Approach 
Similar to the difficulties in discovering and geometrically characterizing CH···O 
hydrogen bonds, little progress has been made in determining the importance or 
specific functions of CH···O hydrogen bonds in biological molecules. As discussed in 
Chapter 1, for SET domain methyltransferases, CH···O hydrogen bonds were proposed 
to aid in cofactor binding, stabilize the sp2 transition state of methyl transfer, and to aid 
NAC formation. 
3.1.1 Tyrosine 335 Mutagenesis 
To test the effect of CH···O hydrogen bonds upon both AdoMet binding, we 
continued our studies with the model system SET7/9. As discussed in the previous 
Chapter, one of the AdoMet methyl CH···O hydrogen bonding partners is an invariant 
tyrosine residue in the SET domain class. Unlike the backbone CH···O hydrogen bond 
acceptor in SET7/9, Tyr335 can be studied through mutagenesis. Thus, to probe the 
functional importance of the Tyr335 CH···O hydrogen bonds, we employed a 
biochemical approach to disrupt them through site-directed mutagenesis of Tyr335 
using natural and unnatural amino acids (UAAs). 
To disrupt the Tyr335 CH···O hydrogen bonds to AdoMet without disturbing the 
conventional hydrogen bond between the tyrosine hydroxyl group and the protein 
backbone, we employed an amber stop-codon suppression strategy to genetically 
substitute Tyr335 with the UAA para-aminophenylalanine (pAF) (171). This amino acid 
44 
 
is isosteric to tyrosine but replaces the hydroxyl group with an amine moiety. Site-
specific incorporation of unnatural amino acids during protein translation can be 
accomplished by introducing a new tRNA and tRNA synthetase that are orthogonal to 
other tRNA-synthetase pairs in the bacterium. Such tRNA synthetases can be generated 
by directed evolution of current synthetases (172). The new tRNA is designed to 
recognize the amber stop codon (UAG), and thus permitting translation to proceed only 
by inserting the unnatural amino acid into the growing polypeptide chain. 
We reasoned that the pAF mutation would abolish all CH···O hydrogen bonding 
by eliminating the Tyr335 hydrogen bond acceptor, but would not disrupt AdoMet 
methyl group positioning or the conventional hydrogen bond, enabling direct 
comparison of the structural, functional, and thermodynamic properties between WT 
and the Y335pAF mutant. In addition to the pAF substitution, we also generated a 
Y335F mutant to abolish all CH···O hydrogen bonding in addition to the conventional 
hydrogen bond formed by the tyrosine hydroxyl group. We reasoned that a comparison 
of the properties of the Y335F and Y335pAF mutants would offer insight into the 
specific functions of these CH···O hydrogen bonds. 
3.1.2 NMR spin-relaxation 
As previously mentioned, one possible role of CH···O hydrogen bonds is to 
promote NAC formation by aligning the AdoMet methyl group for nucleophilic attack. 
NAC formation is dependent on fixing both the nucleophile (lysine), and electrophile 
(AdoMet) into a reactive conformation. In the case of SET7/9, the lysine residue forms 
conventional NH···O hydrogen bonds that likely position it for transfer (48). To probe 
whether the AdoMet methyl group is fixed in space by the CH···O hydrogen bonds in 
the SET7/9 active site, we employed NMR spectroscopy. Biomolecular methyl group 
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dynamics are readily measured by NMR spin-relaxation and relaxation-dispersion 
experiments to probe the ps-ns and μs-ms timescales, respectively (173, 174). One major 
complication in implementing these experiments arises from the unusually large 
number of pathways for dipolar relaxation in methyl groups. In a 13CH3 methyl group, 
there are sixteen separate single quantum coherences along which dipolar relaxation 
can occur, along with several double and zero quantum coherences (175). Relaxation by 
each of these pathways occurs at distinct rates, and thus the measured relaxation rates 
of a 13CH3 methyl group cannot be fit to a mono-exponential curve and yield a single 
rate. To facilitate analysis, the relaxation rates are often split into fast-relaxation and 
slow-relaxation groups, and fit separately (176). Unfortunately, this method, and 
subsequent methods that measure these rates (177, 178), are only semi-quantitative, and 
thus not capable of directly determining the dynamics of a single, isolated methyl group 
without other methyl groups to serve as internal dynamic references. 
The above-mentioned difficulties associated with methyl group relaxation 
measurements and fitting are easily circumvented by using deuterated methyl 
isotopomers. Carbon and deuterium relaxation can be accurately measured using 
13CHD2 and 13CH2D methyl groups respectively. Due to its spin = 1 state, deuterium 
does not cross-relax appreciably with 13C-H groups, and contributes little in terms of 
direct dipolar relaxation (174). As such, relaxation of a 13CHD2 group can be measured 
and analyzed in a very similar fashion as any isolated 13CH group, with only minor 
corrections to account for 13C-D dipolar relaxation (174). Although deuterium relaxation 
is also straightforward to analyze and can provide accurate methyl dynamics 
measurements, at the time of experimentation, only the 13CHD2 methionine isotopomer 
was commercially available. Therefore, using 13CHD2 methyl relaxation, in combination 
with natural and unnatural amino acid mutations, we sought to determine the functions 
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and importance of the Tyr335 CH···O hydrogen bonds to SET7/9 cofactor binding and 
catalysis. 
3.2 Materials and Methods: 
3.2.1 High-Resolution Crystal Structure PDB Survey 
All co-crystal structures of methyltransferases bound to AdoMet with resolution 
better than 2.00 Å were downloaded and visually inspected before inclusion in the 
AdoMet and protein methyl and methylene CH···O hydrogen bond surveys. Duplicate 
structures were removed, keeping the highest resolution structure of each 
methyltransferase. Electron density from the EDS server was examined to verify model 
quality when available (179). Due to lack of 2Fo-Fc density at the AdoMet methyl group 
position, several structures (2IGT, 1FPX, 1I9G, 2EGV, 2QE6, 2YQZ, 3H6L, 3EEO) were 
not used in the survey. For a few structures (3UJ7, 1N2X, 1ZQ9), analysis was restricted 
to a single copy only of the methyltransferase, due to lack of methyl density. All other 
structures with multiple copies within the PDB file had CH···O hydrogen bonding 
acceptor parameters averaged before analysis. 1N2X, 2ZUL and 1V2X were refined by 
real space parameters using Coot (180) to adjust for model building and refinement 
anomalies before inclusion in the survey. As hydrogen positions for these structures 
were unknown, methyl group hydrogen bonding was based on van der Waals radii (75) 
and non-hydrogen atom angles. In addition to AdoMet methyl groups, all protein side 
chain methyl C···O interactions were analyzed using identical hydrogen bonding cutoffs 
to provide a reference point for analyzing the properties of the AdoMet methyl and 
methylene CH···O hydrogen bonds. 
Four separate criteria were used to determine if methyl groups participated in 
CH···O hydrogen bonding: C···O distance, X-C···O angle, and C···O-Y angle, where X 
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and Y are the non-hydrogen atoms bonded to carbon and oxygen, respectively, and sp2 
oxygen-methyl elevation angle (181). Hydrogen bonding was determined using two 
scenarios 1) For C···O distances less than 3.25 Å, which is the sum of the van der Waals 
radii of carbon and oxygen; and 2) For distances greater or equal to 3.25 Å but less than 
3.70 Å, which is the combined van der Waals radii of a C-H bond and oxygen arranged 
in linear geometry (75). In the former scenario, methyl groups were considered to 
participate in CH···O hydrogen bonding if the C···O distance was less than 3.25 Å, the X-
C···O angle was between 60° and 160°, and the elevation angle was less than 75°. For the 
latter scenario, methyl groups were considered to undergo CH···O hydrogen bonding if 
the C···O distance was less than 3.70 Å, the X-C···O angle was between 85° and 140°, and 
if elevation angle was less than 50°. The C···O-Y angle was required to be greater than 
90° or between 75° and 150° for sp2 or sp3 hybridized oxygen atoms, respectively. In-
house software to measure methyl hydrogen bonding criteria was written using 
MATCH API to manipulate atoms (182). Based on this criterion, ~28% of the protein 
methyl groups surveyed exhibited CH···O hydrogen bonding. Protein methyl groups 
clearly favor relatively long CH···O interactions (mean of 3.8 Å), consistent with 
previous investigations of unpolarized methyl CH···O hydrogen bonding in small 
molecules (183). Distance and angular distributions were volume-corrected by 
multiplying the counts by 1/r3 and 1/sin, respectively (184). Distributions of angles and 
distances were analyzed using Origin (OriginLab).  
To calculate whether the AdoMet methyl CH···O hydrogen bonds were 
significantly different from that of protein methyl groups, we examined the average 
length of each of the two populations. The difference between the mean lengths of each 
population was determined to be 0.31 Å. To establish whether this difference is 
significant, we recombined both populations, and used the Fisher-Yates algorithm (185) 
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to randomly re-order the data set, followed by division into two subsets containing the 
same number of hydrogen bonding interactions as the two original populations (127 
and 9881 members, respectively), and the difference between average lengths 
calculated. This process was repeated 100,000 times, generating a normal distribution 
with an average difference of 0.025 Å and standard deviation of 0.019 Å. These values 
yield a Z-score of 15.2, or a confidence value greater than 99.999%, permitting us to 
reject the null hypothesis. 
In addition to methyl groups, all AdoMet and protein methylene CH···O 
hydrogen bonds were measured and volume corrected as described above for methyl 
groups, with the exception that hydrogens were modeled into the riding positions using 
Chimera (156), and used to define CH···O hydrogen bond angles. In addition to the 
longer distance defined above (<3.70 Å) and the same sp2 oxygen angles, the C-H···O 
angle was required to be between 110° and 250° for sp3 oxygens, and between 100° and 
260° for sp2 oxygens, with a maximum hydrogen elevation angle with the sp2 oxygen 
plane of 60°. 
3.2.2 Protein Expression and Purification  
WT SET7/9 and SET7/9 Y335F were expressed as described previously in Chapter 
2.2.1 . The gene encoding the catalytic domain of SET7/9 (110-366) was subcloned into 
the pBAD vector, followed by site-directed mutagenesis to convert Tyr335 to an amber 
stop codon for introduction of the UAA, pAF. SET7/9 Y335pAF was recombinantly 
expressed in DH10B E.coli containing pDule-pAF vector according to previously 
published protocol for genetic incorporation of UAAs (186). Addition of 1 mM D-pAF 
during induction yielded 100% labeled protein at half the yield of the WT enzyme. The 
remaining enzyme was truncated at residue 334. Induction without pAF yielded only 
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SET7/9 truncated at residue 334. Both SET7/9Y335F and SET7/9 Y335pAF were purified 
as previously described (137), with the exception that gel filtration chromatography was 
performed using a HiLoad Superdex 75 column (GE Healthcare) for pAF mutant. This 
chromatography effectively separated the SET7/9 Y335pAF from the truncated enzyme 
based on the difference in their elution profiles, permitting the latter to be eliminated as 
a contaminant. 
3.2.3 X-ray Crystallography 
WT, Y335pAF, and Y335F SET7/9 crystals were grown by hanging drop vapor 
diffusion at 20° C, as previously described (130) with the following exceptions: 
crystallization solution was mixed in a 1:1 ratio with 10-12 mg/mL SET7/9, 6 mM 
AdoMet or 3.0-4.5 mM AdoHcy, and 2.0 mM of a 10-residue peptide of TAF10 peptide 
or TAF10 K189A peptide in 20 mM TRIS pH 8.0, 100 mM NaCl and 2.0 mM Tris(2-
carboxyethyl)phosphine. Crystallization solutions contained 0.86-1.07 M sodium citrate 
with 100 mM imidazole, pH 7.6-8.4 and 8.0-18 mM NiCl2. Y335F and Y335pAF crystals 
were flash frozen in 1.5 M sodium citrate, with 1.0 mM AdoHcy, 10-13 mM NiCl2 and 
100 mM imidazole pH 8.2-8.7 after 2 days, or 3-5 weeks of crystallization time, 
respectively. For WT SET7/9, crystals were flash frozen in the same cryoprotectant, 
omitting AdoHcy, 16-28 hours after setup to obtain the AdoMet complex, and 3-5 weeks 
after setup for the AdoHcy complex. Data were collected at the Advanced Photon 
Source Synchrotron beamline 21-IDG (LS-CAT), at 100 K and wavelength 0.9786 nm, 
and were processed using HKL2000 (187). The structures were solved by molecular 
replacement in MOLREP (188), with the previously reported protein coordinates of the 
SET7/9 ternary complex (PDB Accession Code 3M53) and AdoMet-bound complex 
(PDB Accession Code 1N6A) (47, 130) as the search models. Model building and 
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refinement were carried out using Coot (180), MiFit (version 2010.10 
http://code.google.com/p/mifit), and REFMAC (189), respectively. . The quality of the 
final model was verified by Molprobity (190). CNS was used to generate simulated 
annealing omit maps for each of the different structures (191). In the SET7/9 Y335pAF 
structure, K189 of the TAF10 peptide, pAF and AdoHcy were omitted. In the SET7/9 
Y335F structure, K189, Phe335, and AdoHcy were omitted. In each of the WT SET7/9 
structures, His293, Gly264, and cofactor were omitted. RMSD values were calculated 
and structural figure rendered in PyMol (Schrödinger, LLC). Exhaustive attempts to 
crystallize the SET7/9 Y335pAFAdoMet and SET7/9Y335pAFAdoMetTAF10K189A 
complexes were unsuccessful. 
3.2.4 Isothermal Titration Calorimetry (ITC) 
SET7/9 Y335pAF•TAF10 and SET7/9 Y335F•TAF10 peptide ITC experiments 
were performed using a MicroCal VP-ITC calorimeter (GE Healthcare), as previously 
described for WT SET7/9 with identical buffer and temperature conditions (130). 
Stoichiometry constants ranged from 0.81-1.05. Kinetic ITC fits were performed on 
triplicate WT SET7/9•AdoMet binding experiments, as previously described (192). 
3.2.5 Intrinsic Fluorescence Binding Assays 
The weak cofactor affinities displayed by the SET7/9 Y335 mutants precluded 
analysis of their binding constants by ITC. To measure cofactor binding to the Y335 
mutants, a fluorescence binding assay was developed that quantifies the change in 
intrinsic fluorescence of the active site tryptophan 352 that stacks adjacent to the 
cofactor adenine ring (47). Dissociation constants for AdoMet and the product AdoHcy 
were calculated using intrinsic fluorescence measurements in triplicate using a Safire II 
plate reader (Tecan Group Ltd.) and round-bottom, black Costar 96-well plates 
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(Corning). Buffer conditions were identical to previous SET7/9 ligand binding studies 
by ITC (20 mM sodium phosphate pH 7.0 and 100 mM NaCl), as described in Chapter 
2.2.6 . Varying concentrations of ligand were added to 1.75 μM of SET7/9 Y335pAF or 
Y335F, and fluorescence monitored between 320 and 390 nm at 37°C after excitation at 
280 nm. The measured fluorescence change was ~3-5 fold, depending on the enzyme 
and ligand used. Resulting fluorescence profiles were fit to a Gaussian function, and 
then calculated amplitudes were plotted as a function of ligand concentration, and 
dissociation constants determined by fitting in Prism (Graphpad). The fraction bound 
was determined by using the fitted saturation point of each individual experiment as = 
1.0. For certain experiments, non-specific binding was additionally observed, as 
evidenced by a linear trend at high ligand concentration. This non-specific binding was 
subtracted out using a linear fit model. Resulting binding curves were verified to 
produce dissociation constants within error of those calculated using a fitting model 
with a linear non-specific binding term included in the fitting procedure. When 
measured separately, neither ligand nor SET7/9 showed discernible fluorescence change 
with increasing concentrations. To control for differences between ITC and fluorescence 
data, a binding experiment was first conducted for AdoHcy and WT SET7/9, yielding a 
dissociation constant (60 ± 5 μM and 134 ± 36 μM by ITC and fluorescence experiments, 
respectively) that differed by only two-fold compared to the KD value measured by ITC. 
3.2.6 Differential Scanning Calorimetry (DSC) 
Melting enthalpy and temperatures of WT SET7/9, Y335F and Y335pAF were 
measured using a nanoDSC calorimeter (TA Instruments), with a scan rate of 1°C/min 
from 18° to 100°C at 3 atm constant pressure and a sample concentration of 0.9 mg/ml 
protein. Buffer conditions were identical to binding assay conditions. Data were 
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analyzed using nanoAnalyze software (TA Instruments), and the figure was prepared 
using Origin 8.5 (OriginLab). 
3.2.7 NMR Spectroscopy 
2D NMR and spin-relaxation experiments on WT SET7/9AdoMet and SET7/9 
Y335FAdoMet were carried out on a 600-MHz Avance Bruker NMR spectrometer 
equipped with a triple resonance cryoprobe at 298 K. The SET7/9 Y335F sample used for 
chemical shift determination contained 0.1 mM 13CH3-AdoMet (generated as previously 
described in Chapter 2.2.2 ) and 1.0 mM SET7/9 Y335F to enable saturation of the 
cofactor by enzyme. 13CHD2-AdoMet experiments were performed in: 20 mM sodium 
phosphate, pH 7.5, 100 mM NaCl, and 0.5 mM TCEP, in 98% D2O. 13CHD2-AdoMet was 
enzymatically synthesized from 13CHD2-methionine and ATP as previously described in 
Chapter 2.2.2. NMR data were processed using NMRPipe/NMRDraw(159) and iNMR 
(www.inmr.net), and analyzed using Sparky (160). 
13C relaxation rates were determined using 13CHD2-AdoMet and a perdeuterated 
protein sample (see above), with a constant R1 spin-lock power of 3500 Hz to eliminate 
any Rex contributions. 13C relaxation rates were measured using pulse sequences (193, 
194) that were modified to incorporate deuterium decoupling for the duration of the 
experiments, as previously described (173). WT SET7/9 correlation time (21 ns) was 
calculated from its structure (1N6A) (47) using HYDRONMR (195, 196), and D2O 
viscosity of 1.100 cP (197). Relaxation rates were analyzed as previously described (174), 
with the exception that the methyl C-H distance was set to 1.08 Å, based on our 
quantum chemistry optimizations of the AdoMet methyl group in the presence of a 
CH···O hydrogen bonding partner, using in-house written software that incorporates 
spectral density analysis into an extended Model-Free formalism (193). Due to the 
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inability to generate stable perdeuterated SET7/9 Y335F and Y335pAF, we were unable 
to measure relaxation rates for these mutants. Relaxation data was fit using Prism 5 
(Graphpad). 
 
Figure 3.1: Selective 13C R1ρ relaxation and relaxation-dispersion pulse sequence for 13CHD2-methyl 
groups. 
Adapted from previously published pulse sequence (194). Adapted previously published figure courtesy 
of Alex Hansen 
 
Figure 3.2: 13C R1 relaxation pulse sequence for 13CHD2-methyl groups. 
Adapted from previously published pulse sequence (193). Adapted previously published figure courtesy 
of Alex Hansen 
Order parameters for AdoMet bound in the active site of methyltransferases 
were calculated for AdoMet molecules using the same pool of structures as the PDB 
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survey. AdoMet molecules were aligned by the sulfur and two adjacent methylene 
carbon atoms using the alignment protocol in PyMol (Schrödinger, LLC). Free AdoMet 
order parameters were calculated from a 10 ns MD simulation of AdoMet previously 
verified to correctly model the methyl group electronic environment in Chapter 3.2.9 . 
The AdoMet molecules in the MD simulation were aligned by the center of mass of the 
same three atoms as above, followed by an exhaustive rotation search. Order 
parameters were calculated from these ensembles as previously described (198, 199). 
3.2.8 Radiometric AdoMet Assays 
Purified WT SET7/9 (0.06-0.25 M), and the mutants SET7/9 Y335pAF (10 M) 
and SET7/9Y335F (0.3 M), and were used in methyltransferase assays (200) with 
biotinylated TAF10 peptide (480 M) (130). Assays contained 25 mM NaCl, 100 mM 
bicine pH 9.0, various concentrations of [3H-methyl] AdoMet (diluted to specific 
activities from 0.18 to 1.8 Ci/nmole with purified AdoMet (201) in a final volume of 20 
L and incubated at 37°C. Assays were terminated at 1, 30, and 2 min for WT SET7/9, 
SET7/9 Y335pAF, and SET7/9Y335F respectively (rates measured were linear over these 
times), by addition of an equal volume of 200 mM MES pH 5 prior to addition of a two-
fold molar excess of immobilized streptavidin resin (UltraLink; Pierce Biotechnology, 
Inc.). After 30 minutes at room temperature for binding of the peptide, the resin was 
collected by centrifugation, washed three times with 300 mM NaCl, and transferred to a 
vessel for measurement of tritium incorporated during the assay by liquid scintillation 
spectroscopy. For each activity determination, two separate control assays (without 
enzyme and without peptide substrate) were conducted in concert for background 




Single turnover assays using WT SET7/9 were performed in analogous 
conditions to steady state experiments, except with increased concentrations of AdoMet 
(60 M), TAF10 peptide (2.0 mM), and enzyme (70-140 M), and that the quench was 
accomplished using an equal volume of 7 M acetic acid. Time points were taken 
between 0.1 and 13 seconds after reaction initiation. A chemistry rate constant was 
determined by fitting the data to a single mono-exponential curve (202). 
3.2.9 Quantum Mechanical (QM) Modeling 
Using the crystal structure of SET7/9 Y335pAF•TAF10•AdoHcy, a minimal 
active site model was generated for the both the SET7/9 Y335pAF•AdoHcy and SET7/9 
Y335pAF•AdoMet complex to determine the position of the SET7/9 Y335pAF amine 
hydrogens and AdoMet methyl group. All hydrogens were added automatically using 
UCSF Chimera (156) followed by ONIOM/DFT methods (203) in Gaussian 09 (Gaussian 
Inc.) with solvation using the Polarizable Continuum Model (153). For the SET7/9 
Y335pAF•AdoHcy complex, atoms closest to the pAF-amine group were modeled 
using B3LYP/6-311g+(2d,p) (151, 204), including all aniline atoms, the AdoHcy sulfur 
and adjacent methylene groups, the carbonyl of Ala295, and amide and Cα of Asn296, 
while remaining atoms were modeled using B3LYP/3-21G* (157, 158). All hydrogen 
atoms and the pAF amine nitrogen were allowed to optimize, while other atoms were 
held frozen. For the SET7/9 Y335pAF•AdoMet complex, the methyl group was also 
modeled using B3LYP/6-311g+(2d,p) and allowed to optimize its position. 
For the CH···O geometry and energy calculations, all structures were geometry 
optimized using B3LYP/6-31g+(2d,p) in Gaussian 09 (Gaussian Inc.) with solvation 
using the Polarizable Continuum Model (153). The reactant state structures were 
calculated with no restraints. The methyl transfer transition state structure was 
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calculated using QST2 and QST3 algorithms. CH···O hydrogen bonders were geometry 
optimized with the transition state structure held fixed, or allowed to co-optimize. 
These two separate geometry optimizations yielded identical geometrical and energetic 
results. CH···O hydrogen bond gas-phase interaction energies of the geometry-
optimized structures were calculated using counterpoise calculations (205, 206) with 
MP2/6-31g+(2d,p) (207, 208). 
3.3 Results 
3.3.1 Methyltransferase Structural Survey 
Previous study of SET domain enzymes prompted us to examine whether CH···O 
hydrogen bonds are present in other classes of AdoMet-dependent methyltransferases. 
A survey using typical CH···O hydrogen bonding cutoffs (75) of 43 high-resolution 
crystal structures (< 2.0 Å resolution) of AdoMet-dependent methyltransferases, 
covering all of the major classes revealed that all but one crystal structure displays 
evidence of at least one CH···O hydrogen bond to the AdoMet methyl group (Figure 3.3, 
Appendix A.2). Notably, the single outstanding structure (Accession code 1VPT) has a 
C···O contact whose distance is well within the refinement coordinate error of the 
survey cut-off distance. Of these, half had multiple AdoMet methyl CH···O hydrogen 
bonds. Many of these interactions are closer than 3.25 Å, the van der Waals contact 
distance between a carbon and oxygen atom with no intervening hydrogen atom, 
similar to conventional hydrogen bonds (75). Additionally, we found that in every 
methyltransferase surveyed, at least one of the AdoMet methylene groups adjacent to 
the sulfonium cation engages in hydrogen bonding. The extensive structural 
conservation of AdoMet CH···O hydrogen bonding across diverse methyltransferase 




Figure 3.3: Methyl CH···O hydrogen bonding in AdoMet-dependent methyltransferases. 
(A) Overlay of normalized histograms of methyl group-oxygen distances for AdoMet (green) and protein 
methyl groups (gray) that satisfy hydrogen bonding angular criteria (Chapter 3.2.1). Representative 
examples from the six available classes of AdoMet-dependent methyltransferases illustrating protein or 
cofactor CH···O hydrogen bonding (orange dashed lines) to the AdoMet methyl group. The hydrogen 
bond donor and methyl C···O interaction distances are labeled in each enzyme. (B) Class I: L-isoaspartyl 
O-methyltransferase (PDB accession code 1JG4) (209); (C) Class II: Methionine synthase reactivation 
domain (1MSK) (36); (D) Class III: CobF precorrin-6A synthase (2NPN); (E) Class IV: TrmH tRNA 2´-O 
methyltransferase (1V2X) (210); (F) Class V: SET7/9 KMT (1N6A) (47); and (G) Class VI: RlmN rRNA 
adenosine methyltransferase (3RFA) (211). Although not yet solved at high resolution with AdoMet 
bound, the other known classes also appear to have the potential for CH···O hydrogen bonding (212-214). 
The surprisingly short distances of the AdoMet methyl CH···O hydrogen bonds 
potentially indicates a stronger interaction than typically observed for methyl groups. 
In addition to distance dependence, angular distributions can be indicative of hydrogen 
bond strength (61). It is well accepted that strong hydrogen bonding correlates with a 
tendency toward linearity between the donor, hydrogen and acceptor atoms, or in the 
case of an sp2 acceptor, positioning of the donor within the plane of the acceptor 
orbitals. As such, the angular dependence of AdoMet methyl hydrogen bonding versus 
that of other protein methyl groups can be used as a qualitative indicator of relative 
strength. For this comparison, the elevation angle of the methyl group to the plane of 
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the sp2 oxygen was used, as there is substantial uncertainty regarding the orbital and 
hydrogen positions in an sp3 acceptor as determined by X-ray crystallography. The 
planarity of the sp2 oxygen acceptor orbitals dictates that, in the ideal case, hydrogen 
bonding donor and acceptor atoms should be nearly coplanar. 
 The distribution of angles for all protein methyl groups displays a modest 
tendency towards linearity (Figure 3.4), in contrast to the AdoMet methyl group that 
exhibits stringent coplanarity (Figure 3.4). This observation implies that AdoMet methyl 
CH···O hydrogen bonding is stronger than analogous interactions formed by protein 
methyl groups. The combination of short C···O distances and a strong tendency towards 
co-planarity observed for AdoMet methyl hydrogen bonding is inconsistent with 
typical weak methyl CH···O hydrogen bonding (57, 61). A similar analysis for the 
AdoMet methylene groups yielded a different trend. Unlike the AdoMet methyl group, 
the AdoMet methylene groups behave very similarly to protein methylenes, indicating 
that these groups do not form uniquely strong CH···O compared to protein methylene 




Figure 3.4: Angular distribution of methyl CH···O hydrogen bonds. 
Diagram of (A) elevation angles measured in high-resolution crystal structures of methyltransferases, 
with C···O interaction distances < 3.7 Å that satisfy hydrogen bonding angular criteria (Supplementary 
Methods). Overlay of normalized distributions of methyl group hydrogen bond elevation angles (B) for 
AdoMet (green) and all protein methyl groups that form hydrogen bonds (black). 
 
Figure 3.5: Distance and angular distribution of methylene CH···O hydrogen bonds. 
Diagram of (A) elevation angles and distances measured in high-resolution crystal structures of 
methyltransferases, with C···O interaction distances < 3.7 Å that satisfy hydrogen bonding angular criteria 
(Supplementary Methods). Overlay of normalized distributions of methyl group hydrogen bond 
distances (B) and elevation angles (C) for AdoMet (green) and all protein methyl groups that form 
hydrogen bonds (black). Inset in (C) to distinguish overlapping section of elevation angle plot. 
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3.3.2 Design and testing of CH···O hydrogen bond disruption in SET7/9 
We first performed a series of experiments to assess the feasibility of using the 
Y335F and Y335pAF mutations to probe methyl CH···O hydrogen bonding. Isothermal 
calorimetry experiments on wild type (WT) SET7/9 and the mutants demonstrated 
nearly identical protein substrate binding affinity (Figure 3.6). Thermal denaturation 
studies illustrated that the WT enzyme and Y335pAF mutant maintained equivalent 
stability to WT, whereas the Y335F mutant was mildly destabilized, consistent with the 
loss of the Tyr335-backbone hydrogen bond (Figure 3.6). To further examine the effects 
of these mutants on the enzyme’s overall and active site structure, we determined their 
co-crystal structures of both mutants in complex with AdoHcy and TAF10 peptide (130) 
(Figure 3.7, Figure 3.8, Table 3.1). The coordinates of these complexes and the analogous 
WT complex superimpose with a Cα RMSD of 0.14 Å and 0.22 Å for the Y335pAF and 
Y335F mutants, respectively, illustrating that the WT enzyme and mutants are highly 
structurally similar. Further, the structural hydrogen bond between Tyr335 and the 
carbonyl group of Ala295 is preserved by the pAF substitution, with ideal hydrogen 
bond distance and geometry (Figure 3.7). In comparing both mutants to WT SET7/9, all 
other conventional hydrogen bonds between the enzyme and its ligands, AdoHcy and 
the TAF10 peptide, appear to be preserved, as well as the conformations and positions 
of the active site residues. Taken together, these results emphasize that the mutants 
retains native structure and protein substrate binding while abolishing the CH···O 





Figure 3.6: Calorimetric analysis of SET7/9 Y335pAF. 
(A) Differential scanning calorimetry melting of SET7/9 Y335pAF (), SET7/9 Y335F (), and WT SET7/9 
(). For clarity, 10 points were omitted between each point shown. Isothermal titration calorimetry (ITC) 
analysis of TAF10 binding to (B) SET7/9 Y335pAF (), and (C) Y335F (). Top panel represents titration 
of peptide into SET7/9 Y335pAF, and bottom panel represents binding isotherm with fitted curve. 




Figure 3.7: Structure of the SET7/9 Y335 mutants bound to AdoHcy and the TAF10 peptide. 
(A) Overlay of WT SET7/9 (3M53, gray) (130) and SET7/9 Y335pAF (magenta), with Cα RMSD=0.14 Å. 
AdoHcy and TAF10 peptide are rendered as sticks. (B) Fo-Fc simulated annealing omit map (contoured at 
2.0 ) of SET7/9 Y335pAF (magenta carbon atoms), AdoHcy (green carbons), and TAF10-Lys189 (gold 
carbons). (C) Active site of SET7/9 Y335pAF. The NH···O hydrogen bond between Ala295 and pAF335 





Figure 3.8 Ligand binding modes of WT and SET7/9 Y335pAF are conserved. 
(A) Overlay of TAF10 peptide and AdoHcy in WT SET7/9 (3M53) (gray) and SET7/9 Y335pAF (magenta), 
and SET7/9Y335F (orange). Simulated annealing omit maps calculated at 2.0 σ for (B) Y335pAF and (C) 
Y335F crystals structures. 
Table 3.1: Crystallographic statistics for structures of SET7/9 Y335pAF•TAF10•AdoHcy, SET7/9 









Data collection     
Space group P3221 P3221 P3221 P3221 
Cell dimensions     
    a, b, c (Å) 83.0, 83.0, 95.5 82.3, 82.3, 95.3 83.5, 83.5, 95.8 87.2, 87.2, 94.2 
    α,β,γ ()  90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 120 
Resolution (Å) 50.00-1.60(1.64-1.60) 50-2.56(2.62-2.56) 50.00-1.70(1.74-1.70) 50.00-1.63 
Rmerge (%) 7.7(44.2l) 10.5(51.6) 7.1(48.3) 6.3(56.2) 
I/sI 26.7(3.1) 15.5(2.0) 27.4(7.1) 30.5(4.9) 
Completeness (%) 99.4(94.9) 97.8(84.4) 99.9(100) 99.9(100) 
Redundancy 10.7(4.8) 3.8(3.2) 11.1(11.1) 11.1(11.1) 
     
Refinement     
Resolution (Å) 1.60 2.56 1.70 1.63 
No. reflections 48193 12438 40793 48994 
Rwork/ Rfree 0.20/0.22 0.20/0.26 0.19/0.21 0.19/0.23 
No. atoms 2187 1868 2160 2228 
    Protein 1941 1838 1935 1920 
    Ligand/ion 75 25 66 76 
    Water 171 5 159 232 
B-factors 24.5 44.2 24.8 23.8 
    Protein 23.4 46.9 24.6 23.2 
    Ligand/ion 34.9 71.1 31.5 27.9 
    Water 32 37.6 34.3 34.2 
R.m.s deviations     
    Bond lengths (Å)  0.014 0.014 0.015 0.015 
    Bond angles (º) 1.51 1.38 1.52 1.51 
MolProbity Score     
    Percentile 84% 94% 87% 92% 
    Resolution Range 
(Å) 
1.59 ± 0.25 2.56± 0.25 1.70 ± 0.25 1.63 ± 0.25 
Ramachandran     
    Favored (%) 95.4 93.0 96.3 95.9 
    Allowed (%) 4.6 7.0 3.7 4.1 
    Outliers (%) 0 0 0 0 
To verify that the Y335pAF mutation does not alter methyl group positioning, we 
examined the interactions between the AdoMet methyl group and the mutant by 
modeling AdoMet into the mutant’s active site based on the coordinates of AdoHcy 
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using density functional theory calculations. The calorimetry experiments indicated that 
the Y335pAF substitution does not alter the charge of SET7/9 at this position in the 
active site, as expected due to the low pKa (~5.0) of the aniline group (215), such that its 
amine group could be confidently modeled as neutral. 
After energy optimization, one of the pAF amine hydrogen atoms forms the 
expected hydrogen bond to the Ala295 carbonyl group (Figure 3.7), whereas the second 
amine hydrogen atom occupies the space adjacent to the methyl group, between the 
sulfur and the carbon atoms of the S-C bond (Figure 3.9). To avoid steric clashes with 
AdoMet methyl hydrogen atoms, the methyl group rotates about 5° relative to that in 
the WT enzyme, and the pAF amine group translates 0.2 Å away from the AdoMet 
molecule. Notably, the AdoMet methyl carbon position is virtually unchanged 
compared to the WT enzyme, indicating any decrease in the reaction rate is not likely 
due to an improper methyl carbon alignment in the SET7/9 Y335pAF mutant. Using 
MP2 QM calculations, the 5° rotation of the methyl group was calculated to have little 




Figure 3.9: Model of SET7/9 Y335pAF hydrogen positions based on its crystal structure and density 
functional theory calculations. 
Bound with AdoHcy (A) and AdoMet (B) pAF is rendered with magenta carbon atoms, and 
AdoHcy/AdoMet in green, while backbone carbons are rendered in gray. The structural hydrogen bond 
from the pAF amine to Ala295 is shown in cyan. The AdoMet methyl group is rotated 5˚ from its position 
in WT, as described in Chapter 2.3 , with negligible translational change in position. 
As studies described in Chapter 2 demonstrated that the AdoMet methyl 1H 
chemical shift is highly dependent on its hydrogen bonding state, we analyzed the 
AdoMet methyl 1H chemical shift change when bound in the SET7/9 Y335F active site 
(Figure 3.10). Measurement of the AdoMet methyl 1H chemical shift while bound to the 
Y335F mutant yielded a small upfield chemical shift change (0.1 ppm), indicative of the 
loss of the longer CH···O hydrogen bond between the AdoMet methyl and Tyr335 
hydroxyl groups (Figure 3.10). Attempts to measure the AdoMet methyl chemical shift 
when bound to SET7/9 Y335pAF were unsuccessful due to the low binding affinity and 
intermediate exchange rates, as kinetic ITC analysis found that AdoMet binding is in 




Figure 3.10: WT SET7/9•AdoMet and SET7/9 Y335F•AdoMet methyl 1H chemical shift measurement. 
WT (gray) and Y335F mutant (orange) 13C 2D-HSQC spectra are overlaid. The Y335F mutation, which 
removes only the longer CH···O hydrogen bond, causes a small upfield 1H chemical shift change relative 
to WT SET7/9. The increased linewidth and lower signal to noise of the AdoMet methyl resonance when 
bound to the Y335F mutant is likely due to lower stability of the Y335F mutant preventing long 
experiment time, and decreased AdoMet concentration to enable saturation by SET7/9 Y335F. 
 
Figure 3.11: Representative injection peak and best-fit kinetic parameter trace from AdoMet•WT SET7/9 
ITC experiments. 
The red curves are nonlinear regression fits as previously described (192). Thick line represents the 
regression over the time period used in data fitting (31 seconds to 95 seconds). Faint red line is the 
extrapolation of the regression curve. AdoMet kon was determined from triplicate experiments to be 
slower than diffusion limited = 23800 ± 2800 M-1 s-1. 
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3.3.3 AdoMet Binding and Catalysis by SET7/9 Mutants 
We next examined whether either the Y335F or Y335pAF mutations impaired 
cofactor binding or catalytic efficiency. The Y335F and Y335pAF mutations diminished 
AdoMet binding affinity by three and four orders of magnitude, respectively (Table 3.2, 
Figure 3.12), demonstrating that the loss of Tyr335-mediated CH···O hydrogen bonding 
substantially impaired cofactor binding. Despite the dramatic change in binding 
affinity, the change in catalytic rates of the mutants was comparatively small. The Y335F 
mutant exhibited a kcat nearly identical to WT SET7/9, whereas the kcat of Y335pAF was 
reduced about 60-fold relative to WT (Table 3.2, Figure 3.13). In terms of energetic 
stabilization of the transition state using the Eyring equation, this amounts to a 2.2 
kcal/mol, or 10% increase, of the activation barrier. Single turnover experiments 
indicated that the methyl transfer is rate is nearly within error of the multiple-turnover 
kcat, and well within 2-fold of each other, demonstrating that methyl transfer is limiting 






Table 3.2: WT SET7/9 and mutants Y335pAF, Y335F dissociation constants and catalytic parameters. 
AdoMet KM was calculated using a saturating concentration of TAF10 peptide and varying AdoMet 
concentrations. a,bIsothermal titration calorimetry (ITC) values taken from Chapter 2.3 and Del Rizzo et al. 
(130), respectively. Measured by cintrinsic tryptophan fluorescence assay or dITC. *High error for SET7/9 




WT Y335pAF Y335F 
AdoMet 
a
0.053 ± 0.003 
c
976 ± 209 
c
52 ± 26 
AdoHcy 
c
134 ± 36 
c
839 ± 166 
c
711 ± 500* 
TAF10 
b
4.9 ± 0.1 
d
3.1 ± 0.2 
d




WT Y335pAF Y335F 
kcat (min
-1





) 3.0 ± 0.9 0.0018 ± 0.00044 0.18 ± 0.041 
 
Figure 3.12: Measurement of cofactor binding affinity by intrinsic tryptophan fluorescence. 
(A) Binding of AdoHcy to WT SET7/9 (), SET7/9 Y335pAF (), and SET7/9 Y335F (). (B) Binding of 
AdoMet to SET7/9 Y335pAF () or SET7/9 Y335F (). All dissociation constants are reported in mM. WT 
SET7/9 and AdoMet dissociation constant previously measured as 0.053 ± 0.03 μM by ITC (Table 1) in 




Figure 3.13: Radiometric methyltransferase assays with varying AdoMet concentration. 
Data points and Michaelis-Menten fits are shown for (A) WT SET7/9 (black line) (B) SET7/9 Y335pAF 
(magenta line), and (C) SET7/9Y335F (orange line). All kcat values are listed in min-1, and AdoMet KM 
values are reported in mM. 
 
Figure 3.14: Triplicate single turnover experiments on SET7/9 at 37° C. 
Average parameters from three separate fits: kchem = 1.28 ± 0.19 s-1, maximum product produced = 0.72 ± 
0.04 nmoles. 
3.3.4 Experimental CH···O Hydrogen Bond Strength 
The SET7/9 Y335pAF mutant afforded an unexpected opportunity to 
experimentally assess the effective strength of a CH···O hydrogen bond in 
SET7/9•AdoHcy binding. The cofactor binding constants measured for WT SET7/9 and 
the Y335pAF mutant revealed a six-fold loss in AdoHcy affinity (Table 3.2). This 
diminished affinity was surprising given that AdoHcy lacks the ability to form methyl 
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CH···O hydrogen bonds, and as described above, the AdoMet methylene groups do not 
form strong hydrogen bonding interactions. Of importance, the pAF amine group 
cannot serve as an effective hydrogen bond acceptor, as its lone pair is in resonance 
with the ring To understand the defect in AdoHcy binding, we examined the 
superimposition of the SET7/9 Y335pAF•TAF10•AdoHcy peptide structure with the 
analogous WT complex. The aligned structures reveal a subtle shift in the position of 
the AdoHcy adenine group relative to the pAF335 side chain in the mutant ternary 
complex compared to the WT enzyme (Figure 3.7). Examining the interactions between 
the cofactor’s adenine group and the invariant Tyr335 via a survey of 16 cofactor-bound 
structures of SET7/9 (resolution < 2.0 Å) illustrated a mean distance of 3.42  0.06 Å 
between the Tyr335 hydroxyl group and the C8 atom in the cofactor’s adenine group. 
These distances are indicative of an aromatic CH···O hydrogen bond between the 
Tyr335 hydroxyl and adenine C8 atom (denoted as the C8H···O hydrogen bond). 
Conversely, in SET7/9 Y335pAF, the pAF amine group and the adenine C8 atom are 
separated by 3.71 Å with a refinement coordinate error of  0.05 Å (Figure 3.7). This 
distance is statistically different from those measured in the WT enzyme complexes 
(Table 3.3) and is indicative of a van der Waals contact between the pAF amine group 
and the adenine C8 atom in contrast to a hydrogen bond. Thus, these results reveal an 
unexpected role for the invariant tyrosine in adenine C8H···O hydrogen bonding, in 
addition to its interactions with the AdoMet methyl and methylene groups. 























As the shift in the cofactor adenine moiety was the only notable change in the 
SET7/9 Y335pAF structure, we attributed the six-fold decrease in AdoHcy affinity to the 
loss of the adenine C8H···O hydrogen bond. Based on this decrease, we estimated the 
stabilization energy of this interaction at ΔΔG ≈ -1 kcal/mol, taking into account the 
difference in AdoHcy binding constants of WT SET7/9 and Y335pAF mutant. This free 
energy value is on the order of weak conventional hydrogen bond stabilization energy, 
demonstrating that CH···O hydrogen bonding can be relatively strong. Further, 
quantum calculations suggested that the adenine C8 forms CH···O hydrogen bonds 
with the tyrosine hydroxyl with an optimal distance of ≈ 3.5 Å, and gas-phase hydrogen 
bond energy of -1.4 kcal/mol, in good agreement with our measured ΔΔG. The AdoHcy 
methylene groups do not form energetically favorable CH···O hydrogen bonds, and 
thus do not contribute to the loss of binding affinity. Finally, the C8H···O hydrogen 
bond strength reported here is in good agreement with a previous experimentally 
determined value of a biological CH···O hydrogen bonds as discussed in Chapter 1. 
3.3.5 Quantum Chemistry Calculations on Reactant and Transition States 
To further evaluate our binding and kinetics data, we used quantum chemistry 
calculations to determine the energetic effect of CH···O bonding on AdoMet binding 
and transition state stabilization (Figure 3.15). After geometry optimization to either the 
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transition or reactant state, interaction energies were calculated between these states 
andoxygen acceptors. In both the reactant and transition states, CH···O hydrogen 
bonding was highly favorable, and of a similar strength to conventional hydrogen 
bonds, between -5-10 kcal/mol (216). Interestingly, the CH···O hydrogen bonds 
energetically stabilize both the transition state and reactant state similarly (Figure 3.15). 
Approximately similar stabilization of both the reactant and transition state is analgous 
to a substantial change in binding affinity, but a relatively minor effect on the turnover 
number (217), consistent with our measured binding and kinetics table for WT SET7/9 
and the Tyr335 mutants (Table 3.2). Accordingly, theTyr335-mediated CH···O hydrogen 
bonds promote tight binding to AdoMet as well as the transition state, but do not 




Figure 3.15: Quantum chemistry geometry optimizations and interaction energies of AdoMet and methyl 
transfer transition state CH···O hydrogen bonds. 
(A) Reactant and (B) transition state CH···O hydrogen bonds to backbone carbonyl group, respectively. 
(C) Reactant and (D) transition state CH···O hydrogen bonds to tyrosine side chain, respectively. C···O 
distances are depicted in orange. 
3.3.6 Methyl Group Dynamics and Pore Constriction 
As previously mentioned, one mechanism by which methyl transfer can be 
catalyzed is through NAC formation. It is conceivable that Tyr335, in combination with 
the backbone CH···O hydrogen bond between AdoMet and the His293 carbonyl group, 
may contribute specifically to catalysis through methyl group positioning To evaluate 
whether CH···O hydrogen bonds could contribute to NAC formation by restricting 
methyl group motion while bound to the active site, we undertook experiments to 
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examine how the aperture of the oxygen-lined methyl transfer pore may change during 
catalysis. To accomplish this, we solved two additional structures of WT SET7/9 ternary 
complexes bound to a non-reactive peptide and either AdoMet or AdoHcy to mimic the 
movements of the methyl transfer pore throughout the methyl transfer reaction. 
Analysis of these structures in combination with other high-resolution liganded 
structures of SET7/9 indicates that the methyl transfer pore contracts as the methyl 
group translates from the reactant to the product state (Figure 3.16). The 
SET7/9•AdoMet binary complex exhibits the largest methyl transfer pore area, due to 
the methyl group’s steric footprint, with no counteracting electrostatic effects or 
cooperative protein motion from TAF10 peptide binding to offset methyl transfer pore 
widening (Figure 3.16). Similarly, the SET7/9•TAF10 K189A•AdoMet complex also 
displays a relatively wide methyl transfer pore due to the presence of the methyl group, 
but cooperative TAF10 peptide binding in the ternary complex induces further active 
site closure, thus decreasing methyl transfer pore size. The SET7/9•TAF10 
K189A•AdoHcy complex is virtually identical to that of the AdoMet complex, but lacks 
the cofactor methyl group, resulting in a further contraction of the methyl transfer pore. 
By comparison, the SET7/9•TAF10 K189me1•AdoHcy product complex contains a 
methyl group in the active site, but its position is adjacent to the methyl transfer pore 
and thus does not occupy the full steric space of the methyl group observed in the 
AdoMet complexes. Additionally, the presumptive positive charge of the TAF10 Lys189 
ε-ammonium cation in this structure (54, 130, 218) electrostatically attracts the partially 
negatively charged oxygen atoms that form the methyl transfer pore, promoting methyl 
transfer pore contraction. Consequently, the SET7/9•TAF10•AdoHcy complex, which 
contains the positively charged TAF10 K189 side chain but lacks a methyl group, yields 
the smallest methyl transfer pore size. In summary, the steric footprint of the methyl 
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group forces the methyl transfer pore to be larger in the reactant state than in the 
transition or product states. As such, the methyl transfer pore could then sterically 
restrict the motion of the methyl group, and favor NAC formation. 
 
Figure 3.16: Methyl transfer pore contraction in SET7/9. 
(A) Methyl transfer pore size decreases throughout model methyl transfer reaction. Methyl transfer pore 
is defined as the triangle formed by the carbonyl oxygen atoms of His293 and Gly264, and the hydroxyl 
group of Tyr335. PDB accession codes for the other SET7/9•TAF10 complexes are, in order of appearance: 
1N6A (47), 2F69 (169), and 3M53 (130). (B, C) Simulated annealing omit maps and methyl transfer pore 
sizes for crystal structures of SET7/9•TAF10 K189A•AdoMet and SET7/9•TAF10 K189A•AdoHcy 
contoured at 2.5 σ, respectively, with methyl transfer pore triangle shown in red dashes. 
To further probe this question, we analyzed the motion of the AdoMet S-Cmethyl 
axis using the generalized order parameter (S2axis), which measures the amplitude of 
motion of the methyl group on a scale of 0 to 1. Importantly, it can both be back-
calculated from structural ensembles as well as derived using Model-Free analysis and 
NMR spin-relaxation experiments. . For a point of reference for our analysis, the 
average alanine methyl S2axis in proteins, which shares some stereochemical similarity to 
AdoMet due to its  relatively fixed sp3 Cα atom, was previously shown to be 0.8 (219). 
To evaluate the extent of motion of the AdoMet methyl group when not bound to the 
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methyltransferase active site, we calcaluted the S2axis for the free AdoMet using an MD 
simulation previously verified to accurately reflect the level of AdoMet methyl CH···O 
hydrogen bonding in water (220), and found the S2axis = 0.67. Then, to compare the 
methyltransferase-bound S2axis with the free AdoMet, we calculated S2axis from the 
methyltransferase crystal structures used in the PDB survey described above, and found 
that in the crystal structures, the AdoMet methyl group was fixed in position to a 
greater degree than in solution or for the analogous alanine methyl groups, with the 
S2axis = 0.96. Finally, to confirm this observation, we directly measured by NMR 13C spin-
relaxation experiments the methyl motion of AdoMet while bound to SET7/9 (Figure 
3.17). Using the Model-Free formalism (174), the AdoMet methyl group was observed to 
have an order parameter (S2axis) of 1.2 ± 0.2, indicating that the S-C axis of the methyl 
group experiences little to no motion within the methyltransferase active site, and 
substantially less motion than when free in solution. Thus, the oxygen-lined pore 
restricts the motion of the AdoMet methyl group in the active site, optimizing catalytic 




Figure 3.17: (A) R2 and (B) R1 13C spin relaxation fits of 13CHD2-methyl AdoMet bound to SET7/9. 
3.3.7 Discussion 
Collectively, the data presented here illustrate that methyl CH···O hydrogen bonds 
are a highly conserved and important contributor to AdoMet-dependent methylation 
(Figure 3.18). In SET7/9, the Y335 CH···O hydrogen bonds are important for cofactor 
binding and stabilizing the transition state. Further, the methyl transfer pore formed by 
CH···O hydrogen bond acceptors is responsible for limiting the motion of the AdoMet 
methyl group, and may contribute to NAC formation. These findings point toward a 
convergent evolutionary model that is contingent upon methyl CH···O hydrogen 
bonding. 
 
Figure 3.18: Model of AdoMet-dependent methylation. 




As described in Chapter 3.3.2, neither the Y335F nor pAF mutants disrupted the 
CH···O hydrogen bond between the AdoMet methyl group and the backbone carbonyl 
moiety that is strictly conserved in the SET domain class. It is possible that the backbone 
CH···O hydrogen bond has a different role than the Y335 hydrogen bond in catalysis. 
Although it is difficult to analyze the effects of this CH···O hydrogen bond due to its 
immutable nature, future studies may be able to differentiate the role of this hydrogen 
bond by analyzing the properties of the Y335 mutants in varying conditions that probe 
the strength and purpose of the remaining backbone CH···O hydrogen bond. 
The Y335pAF mutation was employed to specifically perturb the SET7/9 active site 
while permitting formation of the backbone-Y335 OH···O hydrogen bond. Still, a small 
defect (about 10% of the barrier) in methyl transfer was detected that was not present in 
the Y335F mutant. There are multiple possibilities that could account for this small 
change. One explanation is that methyl dynamics is greater in this mutant due to the 
loss of CH···O hydrogen bonding. That the Y335F mutant does not display a similar loss 
in catalysis could be an artifact, as it may be masked by a change in the contribution of 
the lost OH···O hydrogen bond between the bound and unbound SET7/9 states. 
Another possibility is that, as has been suggested in other methyltransferases and 
discussed in Chapter 1, SET7/9 undergoes active site compression to facilitate methyl 
transfer. The position of the extra hydrogen atom between the sulfur and methyl group 
of AdoMet could inhibit AdoMet motions parallel to the S-Cmethyl axis that might be vital 
for active site compression. Further, the NMR relaxation methods used here are 
insensitive to these motions. Future studies using 2D infrared spectroscopy may be able 
to detect these motions, and test for them specifically in the pAF mutant. 
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: Conclusions and Future Directions Chapter 4
 With respect to AdoMet-dependent methylation, the experiments presented here 
demonstrate: 1) the existence of CH···O hydrogen bonding in the active site of SET 
domain methyltransferases, 2) the importance of these interactions in methylation by 
SET7/9, 3) that CH···O hydrogen bonding stabilizes both the reactant and transition 
states of methyl transfer and aids in NAC formation in SET7/9, and 4) the strong 
possibility that these interactions and roles are conserved in all classes of AdoMet-
dependent methyltransferases. Together, these results suggest that CH···O hydrogen 
bonding is a universal element of methyl transfer, and potentially a driving force of 
methyltransferase convergent evolution. Despite these discoveries, we are still unable to 
provide a full description of the importance of the importance or roles of CH···O 
hydrogen bonds in SET7/9. Until a method is developed to successfully disrupt all 
CH···O hydrogen bonding in the active site of SET7/9 simultaneously, as well as one at a 
time, we will not be able to appreciate the full affect CH···O hydrogen bonding has on 
both cofactor binding and catalysis in this model methyltransferase. 
In addition to experiments that may be able to disrupt more, or different, CH···O 
hydrogen bonds, other methyltransferase experiments may still be most appropriate to 
attempt using SET7/9. As an example, 2D infrared spectroscopy experiments in 
collaboration with the Kubarych group could be used to evaluate the dynamics of the 
bound AdoMet methyl group at ultrafast timescales, and potentially to follow the 
dynamics of the methyl group as methyl transfer proceeds. These experiments could 
define the reaction coordinate of the methyl transfer reaction at a level of detail 
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unprecedented in enzymology. SET7/9 is an ideal choice for such experiments, due to its 
high solubility, tight AdoMet binding, and good yield from bacterial expression. 
Despite the advantages of using SET7/9 as a model system, the experiments 
described in this dissertation represent only a single methyltransferase case study. To 
elaborate, we found using preliminary single turnover assays at lower temperature that 
in WT SET7/9 the methyl transfer reaction is relatively temperature insensitive, 
suggesting that the activation barrier to methylation is surprisingly small. Temperature 
dependent experiments on other methyltransferases, however, have shown a wide 
variation in activation barriers of enzymatic methylation, from 7 kcal/mol to 19 kcal/mol 
(221, 222). This variability suggests that the various forces that facilitate methylation are 
not present in the same magnitude for all methyltransferases. Correlatively, it is 
possible that CH···O hydrogen bonding plays different roles either within or between 
different methyltransferase classes. Although the SET domain is well-conserved within 
Class V enzymes, there are variations that lead to differing hydrogen bond distances 
and angles. For example, within Class I, the large divergence in sequence in the 
AdoMet-binding pocket has led to a wide variety of CH···O hydrogen bond acceptors in 
unique positions. Seemingly the most common acceptor in Class I methyltransferases is 
the backbone carbonyl group, similar to Class V enzymes. In Class I, a backbone 
carbonyl acceptor is usually found in a position analogous to that of the invariant 
tyrosine hydroxyl group in Class V (Appendix A.2). As carbonyl and tyrosine acceptors 
have differing properties in terms of preferred angles, distances, and hydrogen bond 
strength, this switch could change how CH···O hydrogen bonding affects cofactor 
binding and methyl transfer. As a result, similar investigations to those presented here 
should be carried out in all methyltransferase classes to fully understand how CH···O 
hydrogen bonding contributes to AdoMet-dependent methylation. 
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As such, we have begun to investigate other methyltransferase classes. As 
described in Appendix A.1, we have used chemical shift measurements to determine 
that the Class I enzyme TylM1 forms CH···O hydrogen bonds, similar to the SET 
domain enzymes. Efforts are currently underway in the Trievel group to prepare 
members of each of the other methyltransferase classes for evaluation by chemical shift 
in a similar manner, or through infrared spectroscopy. We envision these tests as a 
medium-throughput diagnostic to explore CH···O hydrogen bond formation within 
multiple methyltransferases. 
 Although the chemical shift experiments described in Chapter 2 provide direct 
evidence for the existence of CH···O hydrogen bonds in the SET domain active site, 
these experiments are not sufficient to obtain high-resolution details of the geometric 
properties of CH···O hydrogen bonds. Neutron crystallography, as discussed in Chapter 
1, is a fast-evolving technique capable of providing a detailed snapshot of methyl group 
positioning (87). As presented in Appendix A.3, we now have the ability to crystallize 
perdeuterated SET7/9 in complex with methyl-deuterated AdoMet, which facilitates 
neutron crystallography experiments. Further, in collaboration with the Holden group 
at the University of Wisconsin-Madison, we have evidence that TylM1 crystals can be 
grown to the dimensions required for neutron crystallography. In collaboration with 
Dean Myles at Oak Ridge National Laboratory, we are preparing to utilize the next-
generation neutron crystallography beamline, MaNDI, which can be used to collect 
high resolution neutron diffraction data on biomolecular crystals that are as small as a 
tenth the volume as needed at traditional neutron beamlines. Using this new resource, 
we anticipate being able to solve high-resolution neutron structures of multiple 
methyltransferases to directly observe CH···O hydrogen bond formation and properties 
within methyltransferase active sites. 
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In addition to chemical shift and neutron crystallography experiments on TylM1, 
we also are planning to biochemically characterize the CH···O hydrogen bonds in this 
enzyme using a similar strategy to that used in Chapter 3. TylM1 contains two tyrosine 
residues that appear to be forming CH···O hydrogen bonds with the AdoMet methyl 
group based on the chemical shift experiments and calculations described in Appendix 
A.1. These two tyrosines are prime candidates for substitution by both phenylalanine 
and pAF to examine the effects of cofactor binding and catalysis by removing CH···O 
hydrogen bonds. Our working hypothesis is formulated from the data described in 
Chapter 3, in that the CH···O hydrogen bonds will be vital for cofactor binding and 
stabilizing the transition state. One advantage of working with TylM1 is that we may be 
able to also examine the effects of removing both tyrosine CH···O hydrogen bonds 
simultaneously using combinations of pAF and phenylalanine substitutions to replace 
each of the tyrosine residues. In this manner, we may be able to achieve a more in depth 
view of the functions of individual CH···O hydrogen bonds both separately and in 
concert. Thus, the investigations of TylM1 serve not only to validate the possibilities 
raised by the SET7/9 experiments, but also to gain an in-depth understanding of the 
functions of CH···O hydrogen bonds in methylation. 
As discussed in Chapter 1, methyltransferases are involved in many disease 
states, and are now being targeted to treat several disorders. Multiple strategies that 
utilize CH···O hydrogen bonding in inhibitor design have very recently been 
discovered. For example, Tolcapone, an inhibitor of the Class I methyltransferase 
Catechol-O-methyltransferase used to treat Parkinson’s disease, was recently shown to 
feature a hydrogen bond acceptor pointing towards the AdoMet methyl group when in 
complex with the enzyme, likely enhancing its binding affinity by forming a CH···O 
hydrogen bond (223). Using a different approach, Luo et al. introduced a new class of 
83 
 
transition-state analogue inhibitors based on the Trievel group’s work on CH···O 
hydrogen bonding in the Class V methyltransferases. These inhibitors are derivatives of 
the natural product inhibitor sinefungin, in which the methyl sulfonium cation is 
substituted by an amine-methylene group that forms conventional NH···O hydrogen 
bonds in place of the methyl CH···O hydrogen bonds, as described in Chapter 2. Luo et 
al. designed a strategy to synthesize selective transition-state analogue inhibitors by 
derivitizing sinefungin with various alkyl groups, and demonstrated the strategy’s 
feasibility using the Class V methyltransferase SETD2 (224). In the future, the Luo 
laboratory plans to use this strategy to develop specific inhibitors for many Class V 
enzymes. In a similar example, the Class I enzyme PRMT5 was shown to be powerfully 
inhibited by a sinefungin derivative that hydrogen bonds to the methyltransferase’s 
putative methyl CH···O hydrogen bond acceptors. In summary, inhibitors that mimic 
either the AdoMet methyl CH···O hydrogen bond donors or acceptors are a promising 
avenue for future drug development that necessitates understanding these interactions 
within the context of methyltransferase structure and mechanism. 
As examined in Appendix A.3, methyl CH···O hydrogen bonding is not limited 
to just polarized methyl groups such as AdoMet and methyllysine, but is surprisingly 
prevalent in nonpolar methyl groups in proteins. The question still remains: how 
important are these interactions in non-polar methyl groups to protein structure, 
folding, and dynamics? We have begun molecular dynamics simulations in 
collaboration with the Brooks group to answer this question by removing methyl 
CH···O hydrogen bonds from proteins by deleting the charge on methyl hydrogen 
atoms. Preliminary analysis of these simulations suggests that methyl CH···O hydrogen 
bonds are important to protein folding and dynamics by tempering the hydrophobic 
effect. As a result, the protein is able to tolerate methyl groups that are exposed to 
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water, and avoid kinetic traps in the folding pathway. This model corroborates the 
finding discussed in Chapter 1 that large sections of the surface of lysozyme interact 
with water solely through CH···O hydrogen bonds (110). We believe that this technique 
could be used to analyze the importance of hydrogen bonds in many benchmark 
biological systems, including DNA and RNA, and could provide crucial information on 
the importance and functions of CH···O hydrogen bonds in many contexts. 
Although there are still many questions involving the functions of CH···O 
hydrogen bonding in proteins, as discussed in Chapter 1.2.3, there have been few 
studies on the importance of CH···O hydrogen bonding in nucleic acids. Analogously to 
the use of site-specific unnatural amino acid mutations in proteins as described here, it 
may be possible to evaluate the effects of CH···O hydrogen bonding in nucleic acids by 
utilizing modified nucleotides. For example, the combined use of 8-aza-
2’deoxyadenosine(225) and 2-aza-2’deoxyadenosine (226) could remove the putative 
CH···O hydrogen bonds from Hoogsteen and Watson-Crick base-pairing, respectively. 
Quantum chemistry calculations predict that these modified bases would impact base-
pair stability, and previous study indicates that the 2-aza base destabilizes duplex 
formation (227). These bases could also be used to analyze the importance of CH···O 
hydrogen bonding in RNA folding, and in protein-nucleic acid recognition. 
Another important outcome of the work described in this dissertation is the facile 
and inexpensive means to create specifically labeled AdoMet by enzymatic synthesis. 
Through the use of methyltransferases, methyl-labeling could be employed to site-
specifically label many different biological systems. This property could be especially 
useful for NMR spectroscopy, as a means to examine the structure and dynamics, or as 
an assignment strategy, for especially large biomolecules. For example, rRNA 
85 
 
methyltransferases could be used to site-label the ribosome with 13C methyl groups, and 
these methyl groups could then be used to probe ribosome dynamics. Similarly, methyl 
groups placed at the ends of very long DNA molecules could be used to examine the 
effects of length on DNA dynamics, as currently NMR spectroscopy is limited to short 
nucleotide sequences. Histone or DNA methyltransferases could be employed to label 
nucleosomes, or nucleosomal arrays, and could then probe the relationship of 
nucleosome dynamics and genetic regulation. These are only a few of the many possible 
systems that current NMR techniques could examine in great detail through the use of 
site-specific methyl labeling. 
Similarly, the genetic incorporation of unnatural amino acids into proteins is 
another new technique that holds great promise for many scientific fields. As 
demonstrated here, unnatural amino acids can be a useful tool for enzymologists, as it 
expands the biochemical toolkit beyond the standard 20 amino acids. Given the ever-
increasing number of unnatural amino acids that can be genetically incorporated, and 
the recent opening of the first center for unnatural amino acids research at Oregon State 
University, the number, diversity, and availability of unnatural amino acids to the 
scientific community should rapidly increase over the next few years. Engineering 
enzymes using unnatural amino acids could produce new substrate specificity, or even 
new chemical reactions previously not achievable through standard mutagenesis (228). 
Soon, it may be possible to engineer nearly any functional moiety desired into enzymes 
both to study the fundamentals of enzyme mechanism, and to produce novel enzymes 
for industrial purposes. 
We are only beginning to appreciate the breadth of CH···O hydrogen bonding in 
protein structure and function, and many fundamental questions concerning these 
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interactions in biological molecules and processes remain unresolved, representing 
fruitful avenues for future research. It is important to note that CH···O bonds represent 
a large category of underappreciated interactions in biomolecular structure, including 
CH···N, CH···S (136) and π hydrogen bonds as well as n··· π* interactions that are 
typified in proline residues (229). Similar to CH···O hydrogen bonds, it is conceivable 
that these interactions also play important roles in macromolecular structure and 





A.1 Direct Evidence of CH···O Hydrogen Bonding to AdoMet in Methyltransferase 
TylM1 
As discussed in Chapter 4, the experimental results presented in this dissertation 
are not necessarily applicable to all methyltransferases, and may only reflect SET 
domain enzymes. As a result, we have begun to repeat our analyses of SET7/9 on 
methyltransferases from other structural classes. As Class I is the largest and most 
studied class of methyltransferases, we chose to analyze a Class I enzyme for our 
second case study. TylM1 is a nitrogen dimethyltransferase responsible for completing 
the synthetic pathway of D-mycaminose, a natural product from Streptomyces fradiae 
(230), and the high resolution crystal structure of TylM1 bound to AdoMet revealed 
several potential CH···O hydrogen bond interactions (230). 
Using the protocol for NMR experiments and chemical shift calculations outlined 
in Chapter 2.2, with the expression and purification scheme as previously published 
(230), we sought to verify the position of the hydrogen atoms, and determine the extent 
of CH···O hydrogen bonding in the active site. The calculated chemical shift of the 
methyl group, from the optimized structure shown in Figure A.1, was 3.3 ppm. From 
the NMR experiments, using saturating concentrations of TylM1 and dTDP inhibitor, 




Figure A.1: QM optimization of AdoMet methyl group bound to TylM1 
 
Figure A.2: NMR spectrum of AdoMet bound to TylM1. 
The circle indicates the assigned bound AdoMet methyl group, as it is the only resonance not to appear in 
the control spectra. 
Like SET7/9, the calculated and measured chemical shifts of the AdoMet methyl 
group were in agreement to 0.1 ppm difference. Also like SET7/9, the optimized 
structure demonstrated that the AdoMet methyl group positions itself to optimize 
CH···O hydrogen bonding within the active site. The primary difference between the 
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two enzymes is the magnitude change of the chemical shift from the unbound (3.0 ppm) 
to the bound state (3.2 for TylM1 and 3.7 for SET7/9). There are two contributing 
reasons for this difference. First, the conformation of the AdoMet is different in Class I 
and Class V enzymes, both of which are different from the solution state conformation. 
Each of these three conformations was calculated to have a distinct basal chemical shift, 
with that of the Class I methyltransferases being the furthest upfield of the three. 
Secondly, all of the hydrogen bonding interactions in TylM1 are substantially longer 
than the shortest interaction in SET7/9, which dominates its chemical shift change. 
These differences may have consequences in terms of hydrogen bond strength, as well 
as catalysis, which will be explored in future studies. 
A.2 All AdoMet CH···O Hydrogen Bonds 
PDB Acceptor Residue Acceptor Atom Acceptor Residue Number C···O distance (Å) 
1EIZ ASP O 124 3.38 
1EIZ HOH O 421 3.59 
1EJ0 HOH O 421 3.49 
1EJ0 ASP O 124 3.56 
1G60 HOH O 561/570 3.00 
1G60 HOH O 583 3.00 
1JG4 THR O 73 2.81 
1MSK SAM O4' 1301 3.02 
1MSK HOH O 2174 3.50 
1N2X ASP OD1 103 2.43 
1N2X ASP O 103 3.16 
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1N6A HSD O 293 3.00 
1N6A TYR OH 335 3.48 
1RJD HOH O 905/845 3.49 
1RJD CYS O 202 3.54 
1V2X GLU O 124 2.59 
1V2X HOH O 442 2.96 
1ZQ9 HOH O 4166 3.09 
2AVD SER O 84 3.27 
2AVD ASP OD1 185 3.51 
2B9E ASP O 305 3.44 
2CL5 BIE O3 1218 3.24 
2CL5 ASP O 141 3.37 
2CL5 MET O 40 3.38 
2CL5 HOH O 2205/2186 3.67 
2DPM ASP O 194 3.25 
2NPN TYR O 115 3.08 
2NPN HOH O 4781 3.08 
2NXE HOH O 336 2.82 
2NYU ASP O 104 3.42 
2PLW HOH O 216 3.22 
2WA2 HOH O 2149 3.46 
2ZUL ASN O 305 3.15 
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3AIA HSD O 158 3.06 
3AIA ASP O 157 3.21 
3CKK PHE O 131 2.90 
3DLC GLY O 118 3.29 
3DMF ASN O 305 3.21 
3DOU HOH O 255 3.61 
3DOU ASP O 111 3.68 
3DXY PHE O 142 2.92 
3ELW ASP O 146 3.40 
3G89 ALA O 159 3.12 
3G89 HOH O 425 3.22 
3G89 HOH O 948 3.25 
3G89 HOH O 955 3.38 
3G89 HOH O 686 3.47 
3GCZ ASP O 146 3.17 
3IHT GLY O 114 3.53 
3KKZ GLN O 26 2.83 
3KKZ HOH O 777/701 3.28 
3M6W HOH O 985 3.32 
3M6W HOH O 984 3.41 
3MB5 HOH O 267 3.28 
3MB5 ASP OD2 169 3.40 
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3MB5 GLN O 75 3.53 
3MTE PHE O 105 3.02 
3NDI HOH O 481 3.56 
3NDI HOH O 482 3.56 
3NDI HOH O 480 3.66 
3OOI HOH O 247 3.11 
3OOI TYR OH 207 3.49 
3P97 HOH O 343 2.30 
3P97 HOH O 635 2.94 
3P97 HOH O 462 3.34 
3P97 ASP O 146 3.40 
3PFG HOH O 485 3.39 
3PFG PHE O 118 3.49 
3PFG TYR OH 14 3.49 
3QWP SER O 202 3.08 
3QWP ASN OD1 181 3.25 
3QWP TYR OH 239 3.34 
3RFA GLY O 177 3.26 
3RQ4 PHE O 160 3.22 
3RQ4 HOH O 267 3.34 
3RQ4 TYR OH 217 3.34 
3S8P PHE O 250 3.10 
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3S8P ALA O 269 3.18 
3S8P TYR OH 307 3.40 
3UJ7 ASP O 128 2.85 
     
 
A.3 Perdeuterated Diffraction of SET7/9 Crystals 
As discussed in Chapter 1.2, it is currently difficult to examine the existence and 
geometrical properties of CH···O hydrogen bonds in biomolecules, and one technique 
that holds great promise is neutron crystallography. To achieve sufficient signal-to-
noise ratios to determine high resolution structures often requires large perdeuterated 
crystals. As such, we prepared perdeuterated SET7/9 as described in Chapter 3.2.2, and 
crystallized it using similar conditions to those described in Chapter 3.2.3. A 
perdeuterated crystal, and diffraction to better than 1.6 Å resolution, are shown in 
Figure A.3. With the upcoming commissioning of the MaNDi beamline at Oak Ridge 
National Laboratories, these crystals may be sufficient to determine high-resolution 





Figure A.3: Preliminary diffraction analysis of crystals of deuterated SET7/9 bound to AdoHcy and a 
CD3-monomethyl-TAF10K189 peptide. 
The circle denotes the 1.6 Å diffraction boundary. The left inset panel depicts a perdeuterated SET7/9 
crystal. The right inset panel illustrates reflections beyond the 1.6 Å diffraction ring. 
 
A.4 Side Chain Methyl CH···O Hydrogen Bonds 
The previous chapters have demonstrated the ubiquitous nature and importance 
of CH···O hydrogen bonding to the AdoMet methyl group in methyltransferases. One of 
the more intriguing results to come from these studies is that although side chain 
methyl groups form CH···O hydrogen bonds less preferentially than the AdoMet 
methyl group, they still form at a surprisingly high rate. In total, 28% of all methyl 
groups in proteins were considered to form CH···O hydrogen bonds based on the 
criteria used in our methyltransferase survey in Chapter 3. Further, as was shown in 
Figure 3.3, a substantial percentage of all side chain methyl CH···O contacts are closer 
than 3.7 Å. These findings prompted us to more closely examine the extent of side chain 
methyl CH···O hydrogen bonding in proteins. 
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We analyzed methyl CH···O hydrogen bonding in all neutron structures in which 
methyl hydrogen atoms should be discernible (231), to directly evaluate the level of 
CH···O hydrogen bonding in proteins. Angular and distance cutoffs were similar to that 
used in Chapter 3. Unexpectedly, 36% of all CH···O contacts in proteins fell within the 
angular and distance criteria of being hydrogen bonds. For comparison, the analogous 
percentage of all CH···O bonds, consisting primarily of backbone CH···O bonds in β-
sheets, was discovered by Derewenda et al. to be substantially less than that of methyl 
groups, at 13% (75). This juxtaposition is surprising for multiple reasons: 1) Unlike 
methyl groups, the backbone CH···O hydrogen bonds are predisposed to form by 
secondary structure. 2) Methyl groups typically form weaker CH···O hydrogen bonds 
than the Cα group, due to the unique surrounding sp2 character of the backbone. 3) 
Most methyl groups are thought to reside in the hydrophobic core of the protein, 
sequestered from hydrophilic oxygen atoms. By comparing the distribution of CH···O 
contacts to CH···C van der Waals contacts as a control, the CH···O distribution clearly 
favors shorter interactions than the van der Waals contact, similar to other CH···O 




Figure A.4: Methyl (C)H···O contact distances in proteins. 
Magenta line is the difference between the CH···C (black) and CH···O distributions (orange). 
Importantly, the angular distribution of the CH···O interactions is also consistent 
with hydrogen bond formation. The C-H···O angle distribution displays a greater 
tendency towards linearity than that of C-H···C angles. Similarly, the CH···O elevation 
angle displays a strong trend towards co-planarity. Combined with the distance 
distribution shown in Figure A.4, the angular distributions clearly demonstrate that 




Figure A.5: Methyl C-H···O (orange) and C-H···C (black) angles. 
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